WO2013066438A2
(en)
|
2011-07-22 |
2013-05-10 |
President And Fellows Of Harvard College |
Evaluation and improvement of nuclease cleavage specificity
|
US10704021B2
(en)
|
2012-03-15 |
2020-07-07 |
Flodesign Sonics, Inc. |
Acoustic perfusion devices
|
US9458450B2
(en)
|
2012-03-15 |
2016-10-04 |
Flodesign Sonics, Inc. |
Acoustophoretic separation technology using multi-dimensional standing waves
|
EP2841572B1
(en)
|
2012-04-27 |
2019-06-19 |
Duke University |
Genetic correction of mutated genes
|
WO2014144761A2
(en)
|
2013-03-15 |
2014-09-18 |
The General Hospital Corporation |
Increasing specificity for rna-guided genome editing
|
US9828582B2
(en)
|
2013-03-19 |
2017-11-28 |
Duke University |
Compositions and methods for the induction and tuning of gene expression
|
SG11201508028QA
(en)
|
2013-04-16 |
2015-10-29 |
Regeneron Pharma |
Targeted modification of rat genome
|
CN114015726A
(zh)
*
|
2013-06-17 |
2022-02-08 |
布罗德研究所有限公司 |
用病毒组分靶向障碍和疾病的crispr-cas系统和组合物的递送、用途和治疗应用
|
US20150044192A1
(en)
|
2013-08-09 |
2015-02-12 |
President And Fellows Of Harvard College |
Methods for identifying a target site of a cas9 nuclease
|
US9359599B2
(en)
|
2013-08-22 |
2016-06-07 |
President And Fellows Of Harvard College |
Engineered transcription activator-like effector (TALE) domains and uses thereof
|
US9388430B2
(en)
|
2013-09-06 |
2016-07-12 |
President And Fellows Of Harvard College |
Cas9-recombinase fusion proteins and uses thereof
|
US9737604B2
(en)
|
2013-09-06 |
2017-08-22 |
President And Fellows Of Harvard College |
Use of cationic lipids to deliver CAS9
|
US9340800B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
Extended DNA-sensing GRNAS
|
PT3066201T
(pt)
|
2013-11-07 |
2018-06-04 |
Massachusetts Inst Technology |
Métodos e composições relacionadas com crispr com arng reguladores
|
SG10201700961TA
(en)
|
2013-12-11 |
2017-04-27 |
Regeneron Pharma |
Methods and compositions for the targeted modification of a genome
|
US9068179B1
(en)
|
2013-12-12 |
2015-06-30 |
President And Fellows Of Harvard College |
Methods for correcting presenilin point mutations
|
EP3092049A1
(en)
|
2014-01-08 |
2016-11-16 |
Flodesign Sonics Inc. |
Acoustophoresis device with dual acoustophoretic chamber
|
DE212015000061U1
(de)
|
2014-02-11 |
2017-09-03 |
The Regents Of The University Of Colorado, A Body Corporate |
CRISPR-ermöglichtes Multiplex Genom Engineering
|
WO2015192020A1
(en)
|
2014-06-13 |
2015-12-17 |
Children's Medical Center Corporation |
Products and methods to isolate mitochondria
|
CN113322277A
(zh)
|
2014-06-26 |
2021-08-31 |
瑞泽恩制药公司 |
用于靶向遗传修饰的方法和组合物,以及这些组合物的使用方法
|
CA2956224A1
(en)
|
2014-07-30 |
2016-02-11 |
President And Fellows Of Harvard College |
Cas9 proteins including ligand-dependent inteins
|
US20180250424A1
(en)
|
2014-10-10 |
2018-09-06 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
AU2015332451A1
(en)
|
2014-10-15 |
2017-04-20 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for generating or maintaining pluripotent cells
|
US11680268B2
(en)
|
2014-11-07 |
2023-06-20 |
Editas Medicine, Inc. |
Methods for improving CRISPR/Cas-mediated genome-editing
|
CA3176380A1
(en)
|
2014-11-21 |
2016-05-26 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for targeted genetic modification using paired guide rnas
|
EP3229586A4
(en)
|
2014-12-10 |
2018-10-24 |
Regents of the University of Minnesota |
Genetically modified cells, tissues, and organs for treating disease
|
SG11201704646YA
(en)
|
2014-12-19 |
2017-07-28 |
Regeneron Pharma |
Methods and compositions for targeted genetic modification through single-step multiple targeting
|
EP3256487A4
(en)
|
2015-02-09 |
2018-07-18 |
Duke University |
Compositions and methods for epigenome editing
|
KR102769515B1
(ko)
*
|
2015-03-31 |
2025-02-18 |
소흠, 인코포레이티드 |
세포 또는 유기체의 게놈으로의 DNA 서열의 표적화 혼입을 위한 Cas 9 레트로바이러스 인테그라제 시스템 및 Cas 9 재조합효소 시스템
|
GB201506509D0
(en)
*
|
2015-04-16 |
2015-06-03 |
Univ Wageningen |
Nuclease-mediated genome editing
|
US11708572B2
(en)
|
2015-04-29 |
2023-07-25 |
Flodesign Sonics, Inc. |
Acoustic cell separation techniques and processes
|
US11377651B2
(en)
|
2016-10-19 |
2022-07-05 |
Flodesign Sonics, Inc. |
Cell therapy processes utilizing acoustophoresis
|
AU2016261358B2
(en)
|
2015-05-11 |
2021-09-16 |
Editas Medicine, Inc. |
Optimized CRISPR/Cas9 systems and methods for gene editing in stem cells
|
CN107614680A
(zh)
*
|
2015-05-14 |
2018-01-19 |
南加利福尼亚大学 |
利用重组核酸内切酶系统的最佳化基因编辑
|
JP7396783B2
(ja)
|
2015-06-09 |
2023-12-12 |
エディタス・メディシン、インコーポレイテッド |
移植を改善するためのcrispr/cas関連方法および組成物
|
EP4159856A1
(en)
|
2015-06-18 |
2023-04-05 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
WO2016205749A1
(en)
*
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
US10648020B2
(en)
|
2015-06-18 |
2020-05-12 |
The Broad Institute, Inc. |
CRISPR enzymes and systems
|
CA2990699A1
(en)
|
2015-06-29 |
2017-01-05 |
Ionis Pharmaceuticals, Inc. |
Modified crispr rna and modified single crispr rna and uses thereof
|
WO2017015015A1
(en)
*
|
2015-07-17 |
2017-01-26 |
Emory University |
Crispr-associated protein from francisella and uses related thereto
|
US11459540B2
(en)
|
2015-07-28 |
2022-10-04 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
US11474085B2
(en)
|
2015-07-28 |
2022-10-18 |
Flodesign Sonics, Inc. |
Expanded bed affinity selection
|
CN108472314A
(zh)
|
2015-07-31 |
2018-08-31 |
明尼苏达大学董事会 |
修饰的细胞和治疗方法
|
AU2016308339A1
(en)
|
2015-08-18 |
2018-04-12 |
Baylor College Of Medicine |
Methods and compositions for altering function and structure of chromatin loops and/or domains
|
US11530424B1
(en)
*
|
2015-09-18 |
2022-12-20 |
University Of South Florida |
Efficient CRISPR/HDR-mediated knock-in system and method of use
|
US20190048340A1
(en)
*
|
2015-09-24 |
2019-02-14 |
Crispr Therapeutics Ag |
Novel family of rna-programmable endonucleases and their uses in genome editing and other applications
|
WO2017053879A1
(en)
|
2015-09-24 |
2017-03-30 |
Editas Medicine, Inc. |
Use of exonucleases to improve crispr/cas-mediated genome editing
|
EP3680329B1
(en)
|
2015-10-05 |
2021-06-09 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
|
KR20250013291A
(ko)
|
2015-10-05 |
2025-01-31 |
프리시젼 바이오사이언시스 인코포레이티드 |
변형된 인간 t 세포 수용체 알파 불변 영역 유전자를 포함하는 유전자 변형된 세포
|
EP4491732A3
(en)
|
2015-10-08 |
2025-03-26 |
President and Fellows of Harvard College |
Multiplexed genome editing
|
EP3359644B1
(en)
*
|
2015-10-09 |
2024-05-29 |
Monsanto Technology LLC |
Novel rna-guided nucleases and uses thereof
|
EP3362571A4
(en)
|
2015-10-13 |
2019-07-10 |
Duke University |
GENOM ENGINEERING WITH TYPE I CRISPR SYSTEMS IN EUKARYOTIC CELLS
|
US20190083656A1
(en)
*
|
2015-10-16 |
2019-03-21 |
Temple University - Of The Commonwealth System Of Higher Education |
Methods and compositions utilizing cpf1 for rna-guided gene editing
|
DK3350327T3
(en)
|
2015-10-23 |
2019-01-21 |
Caribou Biosciences Inc |
CONSTRUCTED CRISPR CLASS-2-NUCLEIC ACID TARGETING-NUCLEIC ACID
|
JP7067793B2
(ja)
|
2015-10-23 |
2022-05-16 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
核酸塩基編集因子およびその使用
|
EP3368054A4
(en)
|
2015-10-28 |
2019-07-03 |
Voyager Therapeutics, Inc. |
REGULATORY EXPRESSION USING THE ADENO-ASSOCIATED VIRUS (AAV)
|
CN108471731A
(zh)
*
|
2015-11-06 |
2018-08-31 |
杰克逊实验室 |
大型基因组dna敲入及其用途
|
US11905521B2
(en)
*
|
2015-11-17 |
2024-02-20 |
The Chinese University Of Hong Kong |
Methods and systems for targeted gene manipulation
|
CA3001623A1
(en)
|
2015-11-30 |
2017-06-08 |
Duke University |
Therapeutic targets for the correction of the human dystrophin gene by gene editing and methods of use
|
EP3397261A4
(en)
|
2015-11-30 |
2019-07-03 |
Flagship Pioneering Innovations V, Inc. |
METHODS AND COMPOSITIONS RELATED TO CHOIC DRISOMES
|
US11293029B2
(en)
|
2015-12-07 |
2022-04-05 |
Zymergen Inc. |
Promoters from Corynebacterium glutamicum
|
US11208649B2
(en)
|
2015-12-07 |
2021-12-28 |
Zymergen Inc. |
HTP genomic engineering platform
|
US9988624B2
(en)
|
2015-12-07 |
2018-06-05 |
Zymergen Inc. |
Microbial strain improvement by a HTP genomic engineering platform
|
WO2017099494A1
(ko)
*
|
2015-12-08 |
2017-06-15 |
기초과학연구원 |
Cpf1을 포함하는 유전체 교정용 조성물 및 그 용도
|
WO2017106657A1
(en)
*
|
2015-12-18 |
2017-06-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
CA3009190A1
(en)
|
2015-12-29 |
2017-07-06 |
Monsanto Technology Llc |
Novel crispr-associated transposases and uses thereof
|
WO2017123609A1
(en)
*
|
2016-01-12 |
2017-07-20 |
The Regents Of The University Of California |
Compositions and methods for enhanced genome editing
|
CA3011472A1
(en)
|
2016-01-15 |
2017-07-20 |
The Children's Medical Center Corporation |
Therapeutic use of mitochondria and combined mitochondrial agents for transplantation
|
US20190264186A1
(en)
*
|
2016-01-22 |
2019-08-29 |
The Broad Institute Inc. |
Crystal structure of crispr cpf1
|
US9896696B2
(en)
|
2016-02-15 |
2018-02-20 |
Benson Hill Biosystems, Inc. |
Compositions and methods for modifying genomes
|
WO2017151719A1
(en)
*
|
2016-03-01 |
2017-09-08 |
University Of Florida Research Foundation, Incorporated |
Molecular cell diary system
|
KR102438360B1
(ko)
*
|
2016-03-04 |
2022-08-31 |
에디타스 메디신, 인코포레이티드 |
암 면역요법을 위한 crispr-cpf1-관련 방법, 조성물 및 구성성분
|
WO2017165826A1
(en)
|
2016-03-25 |
2017-09-28 |
Editas Medicine, Inc. |
Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
|
WO2017180694A1
(en)
|
2016-04-13 |
2017-10-19 |
Editas Medicine, Inc. |
Cas9 fusion molecules gene editing systems, and methods of use thereof
|
CN110382692A
(zh)
*
|
2016-04-19 |
2019-10-25 |
博德研究所 |
新型crispr酶以及系统
|
WO2017184786A1
(en)
*
|
2016-04-19 |
2017-10-26 |
The Broad Institute Inc. |
Cpf1 complexes with reduced indel activity
|
WO2017189308A1
(en)
|
2016-04-19 |
2017-11-02 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
CN109415756B
(zh)
*
|
2016-04-28 |
2022-08-09 |
延世大学校产学协力团 |
用于以高通量方式体内评估rna引导的核酸酶的活性的方法
|
US11214789B2
(en)
|
2016-05-03 |
2022-01-04 |
Flodesign Sonics, Inc. |
Concentration and washing of particles with acoustics
|
US11085035B2
(en)
|
2016-05-03 |
2021-08-10 |
Flodesign Sonics, Inc. |
Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
|
US11499158B2
(en)
|
2016-05-13 |
2022-11-15 |
Kaneka Corporation |
Method for modifying plant
|
CN109153988B
(zh)
*
|
2016-05-13 |
2023-04-18 |
株式会社钟化 |
植物的基因组编辑方法
|
JP6967217B2
(ja)
|
2016-05-13 |
2021-11-17 |
株式会社カネカ |
形質転換植物の作製方法
|
KR102628909B1
(ko)
|
2016-05-20 |
2024-01-25 |
리제너론 파마슈티칼스 인코포레이티드 |
다중 가이드 RNAs를 이용한 면역학적 내성 파괴 방법
|
AU2017273713A1
(en)
*
|
2016-06-01 |
2018-10-25 |
Excision Biotherapeutics, Inc. |
Compositions and methods of treatment for lytic and lysogenic viruses
|
WO2017207589A1
(en)
|
2016-06-01 |
2017-12-07 |
Kws Saat Se |
Hybrid nucleic acid sequences for genome engineering
|
AU2017274145B2
(en)
|
2016-06-02 |
2020-07-23 |
Sigma-Aldrich Co Llc |
Using programmable DNA binding proteins to enhance targeted genome modification
|
MX2018014993A
(es)
|
2016-06-14 |
2019-09-06 |
Pioneer Hi Bred Int |
Uso de endonucleasa cpf1 para modificaciones de genoma de planta.
|
US10337051B2
(en)
|
2016-06-16 |
2019-07-02 |
The Regents Of The University Of California |
Methods and compositions for detecting a target RNA
|
EP3455357A1
(en)
*
|
2016-06-17 |
2019-03-20 |
The Broad Institute Inc. |
Type vi crispr orthologs and systems
|
US11293021B1
(en)
|
2016-06-23 |
2022-04-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
ES2915562T3
(es)
*
|
2016-06-24 |
2022-06-23 |
Univ Colorado Regents |
Métodos para generar bibliotecas combinatorias con código de barras
|
WO2018005655A2
(en)
|
2016-06-30 |
2018-01-04 |
Zymergen Inc. |
Methods for generating a bacterial hemoglobin library and uses thereof
|
EP3478845A4
(en)
|
2016-06-30 |
2019-07-31 |
Zymergen, Inc. |
METHOD OF GENERATING A GLUCOSE PERMEASE LIBRARY AND USES THEREOF
|
CN106191057B
(zh)
*
|
2016-07-06 |
2018-12-25 |
中山大学 |
一种用于敲除人CYP2E1基因的sgRNA序列、CYP2E1基因缺失细胞株的构建方法及其应用
|
WO2018013720A1
(en)
*
|
2016-07-12 |
2018-01-18 |
Washington University |
Incorporation of internal polya-encoded poly-lysine sequence tags and their variations for the tunable control of protein synthesis in bacterial and eukaryotic cells
|
JP2019524098A
(ja)
|
2016-07-15 |
2019-09-05 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
非分裂細胞のゲノム編集のための方法と組成物
|
EP4275747A3
(en)
*
|
2016-07-19 |
2024-01-24 |
Duke University |
Therapeutic applications of cpf1-based genome editing
|
CN109844103A
(zh)
|
2016-07-21 |
2019-06-04 |
美克斯细胞有限公司 |
用于修饰基因组dna的方法和组合物
|
CN109790527A
(zh)
*
|
2016-07-26 |
2019-05-21 |
通用医疗公司 |
普氏菌属和弗朗西斯氏菌属的CRISPR1(Cpf1)的变体
|
KR102547316B1
(ko)
|
2016-08-03 |
2023-06-23 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
아데노신 핵염기 편집제 및 그의 용도
|
US11078481B1
(en)
|
2016-08-03 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for screening for cancer targets
|
CA3033327A1
(en)
|
2016-08-09 |
2018-02-15 |
President And Fellows Of Harvard College |
Programmable cas9-recombinase fusion proteins and uses thereof
|
TWI791459B
(zh)
*
|
2016-08-10 |
2023-02-11 |
日商領先基因生技股份有限公司 |
改變真核細胞基因體的標的部位之方法
|
EP3500670B1
(en)
*
|
2016-08-17 |
2024-07-10 |
The Broad Institute, Inc. |
Method for selecting target sequences for guide rna of crispr systems
|
US11352647B2
(en)
|
2016-08-17 |
2022-06-07 |
The Broad Institute, Inc. |
Crispr enzymes and systems
|
WO2018039438A1
(en)
|
2016-08-24 |
2018-03-01 |
President And Fellows Of Harvard College |
Incorporation of unnatural amino acids into proteins using base editing
|
US11078483B1
(en)
|
2016-09-02 |
2021-08-03 |
KSQ Therapeutics, Inc. |
Methods for measuring and improving CRISPR reagent function
|
IL247752A0
(en)
*
|
2016-09-11 |
2016-11-30 |
Yeda Res & Dev |
Compositions and methods for modulating gene expression for site-directed mutagenesis
|
US10650621B1
(en)
|
2016-09-13 |
2020-05-12 |
Iocurrents, Inc. |
Interfacing with a vehicular controller area network
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
KR20230170126A
(ko)
*
|
2016-09-30 |
2023-12-18 |
더 리젠츠 오브 더 유니버시티 오브 캘리포니아 |
Rna-가이드된 핵산 변형 효소 및 이의 사용 방법
|
US11371062B2
(en)
*
|
2016-09-30 |
2022-06-28 |
The Regents Of The University Of California |
RNA-guided nucleic acid modifying enzymes and methods of use thereof
|
CN110139873A
(zh)
|
2016-10-03 |
2019-08-16 |
朱诺治疗学股份有限公司 |
Hpv特异性结合分子
|
DK3757120T3
(da)
|
2016-10-04 |
2022-07-25 |
Prec Biosciences Inc |
Co-stimulerende domæner til anvendelse i genetisk modificerede celler
|
CN110462034A
(zh)
|
2016-10-07 |
2019-11-15 |
综合Dna技术公司 |
化脓链球菌cas9突变基因和由其编码的多肽
|
US11242542B2
(en)
|
2016-10-07 |
2022-02-08 |
Integrated Dna Technologies, Inc. |
S. pyogenes Cas9 mutant genes and polypeptides encoded by same
|
WO2018071672A1
(en)
*
|
2016-10-12 |
2018-04-19 |
The Regents Of The University Of Colorado |
Novel engineered and chimeric nucleases
|
US11306324B2
(en)
|
2016-10-14 |
2022-04-19 |
President And Fellows Of Harvard College |
AAV delivery of nucleobase editors
|
CA3040481A1
(en)
*
|
2016-10-14 |
2018-04-19 |
The General Hospital Corporation |
Epigenetically regulated site-specific nucleases
|
GB2605883B
(en)
|
2016-10-18 |
2023-03-15 |
Univ Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
EP4256951A3
(en)
|
2016-11-04 |
2023-12-06 |
Flagship Pioneering Innovations V. Inc. |
Novel plant cells, plants, and seeds
|
CN106591335A
(zh)
*
|
2016-11-08 |
2017-04-26 |
安徽省农业科学院水稻研究所 |
一种密码子植物化改造的LbCpf1基因及其应用
|
EP4321617A3
(en)
*
|
2016-11-22 |
2024-04-24 |
Integrated DNA Technologies Inc. |
Crispr/cpf1 systems and methods
|
WO2018098480A1
(en)
*
|
2016-11-28 |
2018-05-31 |
The Board Of Regents Of The University Of Texas System |
Prevention of muscular dystrophy by crispr/cpf1-mediated gene editing
|
CN108130342B
(zh)
*
|
2016-12-01 |
2022-01-11 |
中国科学院分子植物科学卓越创新中心 |
基于Cpf1的植物基因组定点编辑方法
|
WO2018107103A1
(en)
*
|
2016-12-09 |
2018-06-14 |
The Broad Institute, Inc. |
Crispr-systems for modifying a trait of interest in a plant
|
US11293022B2
(en)
|
2016-12-12 |
2022-04-05 |
Integrated Dna Technologies, Inc. |
Genome editing enhancement
|
IL267034B2
(en)
|
2016-12-14 |
2025-03-01 |
Ligandal Inc |
Methods and compositions for nucleic acid and protein payload delivery
|
EP3555297A1
(en)
|
2016-12-19 |
2019-10-23 |
Editas Medicine, Inc. |
Assessing nuclease cleavage
|
US20190346460A1
(en)
*
|
2016-12-19 |
2019-11-14 |
The Uab Research Foundation |
Mass spectrometric standards for hemoglobin beta and hemoglobin beta sickle and uses thereof
|
IL266785B2
(en)
*
|
2016-12-22 |
2025-04-01 |
Keygene Nv |
A method for targeted modification of double-stranded DNA
|
WO2018117746A1
(ko)
*
|
2016-12-23 |
2018-06-28 |
기초과학연구원 |
동물 배아의 염기 교정용 조성물 및 염기 교정 방법
|
AU2017382323B2
(en)
*
|
2016-12-23 |
2024-06-13 |
President And Fellows Of Harvard College |
Gene editing of PCSK9
|
US10745677B2
(en)
|
2016-12-23 |
2020-08-18 |
President And Fellows Of Harvard College |
Editing of CCR5 receptor gene to protect against HIV infection
|
US20190382751A1
(en)
*
|
2016-12-28 |
2019-12-19 |
Ionis Pharmaceuticals, Inc. |
Modified crispr rna and uses thereof
|
US11859219B1
(en)
|
2016-12-30 |
2024-01-02 |
Flagship Pioneering Innovations V, Inc. |
Methods of altering a target nucleotide sequence with an RNA-guided nuclease and a single guide RNA
|
CN108265068B
(zh)
*
|
2016-12-31 |
2021-06-15 |
江苏众红生物工程创药研究院有限公司 |
重组精氨酸脱亚胺酶及其产业化制备方法和应用
|
JP7229923B2
(ja)
|
2017-01-06 |
2023-02-28 |
エディタス・メディシン、インコーポレイテッド |
ヌクレアーゼ切断を評価する方法
|
DK3565891T3
(da)
|
2017-01-09 |
2023-07-24 |
Whitehead Inst Biomedical Res |
Fremgangsmåder til ændring af genekspression ved forstyrrelse af transkriptionsfaktor-multimere, der strukturerer regulatoriske sløjfer
|
GB201700380D0
(en)
*
|
2017-01-10 |
2017-02-22 |
Plant Bioscience Ltd |
Methods of increasing seed yield
|
US20180201921A1
(en)
*
|
2017-01-18 |
2018-07-19 |
Excision Biotherapeutics, Inc. |
CRISPRs
|
US11624071B2
(en)
|
2017-01-28 |
2023-04-11 |
Inari Agriculture Technology, Inc. |
Method of creating a plurality of targeted insertions in a plant cell
|
BR112019015578A2
(pt)
|
2017-01-30 |
2020-03-10 |
KWS SAAT SE & Co. KGaA |
Ligação de modelo de reparo a endonucleases para engenharia de genoma
|
CA3053092A1
(en)
*
|
2017-02-10 |
2018-08-16 |
National Agriculture And Food Research Organization |
Method for producing hsl protein having improved catalytic activity for 2-oxoglutaric acid-dependently oxidizing 4-hppd inhibitor
|
JP2020507312A
(ja)
*
|
2017-02-10 |
2020-03-12 |
ザイマージェン インコーポレイテッド |
複数の宿主用の複数のdnaコンストラクトのアセンブリ及び編集のためのモジュラーユニバーサルプラスミド設計戦略
|
US12215329B2
(en)
|
2017-02-15 |
2025-02-04 |
Keygene N.V. |
Methods of targeted genetic alteration in plant cells
|
CN106868031A
(zh)
*
|
2017-02-24 |
2017-06-20 |
北京大学 |
一种基于分级组装的多个sgRNA串联并行表达的克隆方法及应用
|
CN106947779B
(zh)
*
|
2017-02-28 |
2021-02-26 |
中国农业大学 |
利用乳腺生物反应器提高乳汁中褪黑素含量的方法
|
US10687520B2
(en)
|
2017-03-07 |
2020-06-23 |
The Board Of Regents Of The University Of Texas System |
Generation and correction of a humanized mouse model with a deletion of dystrophin exon 44
|
US11898179B2
(en)
|
2017-03-09 |
2024-02-13 |
President And Fellows Of Harvard College |
Suppression of pain by gene editing
|
EP3592381A1
(en)
*
|
2017-03-09 |
2020-01-15 |
President and Fellows of Harvard College |
Cancer vaccine
|
JP2020510439A
(ja)
|
2017-03-10 |
2020-04-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
シトシンからグアニンへの塩基編集因子
|
CN106978428A
(zh)
*
|
2017-03-15 |
2017-07-25 |
上海吐露港生物科技有限公司 |
一种Cas蛋白特异结合靶标DNA、调控靶标基因转录的方法及试剂盒
|
KR102454284B1
(ko)
*
|
2017-03-15 |
2022-10-12 |
더 브로드 인스티튜트, 인코퍼레이티드 |
신규 cas13b 오르소로그 crispr 효소 및 시스템
|
CA3057192A1
(en)
*
|
2017-03-23 |
2018-09-27 |
President And Fellows Of Harvard College |
Nucleobase editors comprising nucleic acid programmable dna binding proteins
|
WO2018175712A1
(en)
*
|
2017-03-23 |
2018-09-27 |
The Government Of The United States Of America As Represented By The Secretary Of The Army |
Recombinant adeno-associated virus-paraoxonase 1-ifii particles and the methods of making and using thereof
|
WO2018175924A1
(en)
|
2017-03-24 |
2018-09-27 |
The Broad Institute, Inc. |
Methods and compositions for regulating innate lymphoid cell inflammatory responses
|
WO2018183908A1
(en)
|
2017-03-31 |
2018-10-04 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating ovarian tumors
|
CN108690845B
(zh)
*
|
2017-04-10 |
2021-04-27 |
中国科学院动物研究所 |
基因组编辑系统和方法
|
WO2018191663A1
(en)
*
|
2017-04-14 |
2018-10-18 |
Monsanto Technology Llc |
Methods and compositions for herbicide tolerance in plants
|
WO2018191715A2
(en)
*
|
2017-04-14 |
2018-10-18 |
Synthetic Genomics, Inc. |
Polypeptides with type v crispr activity and uses thereof
|
EP3612023A4
(en)
|
2017-04-20 |
2021-05-12 |
Egenesis, Inc. |
Methods for generating genetically modified animals
|
ES2992912T3
(en)
|
2017-04-21 |
2024-12-19 |
Massachusetts Gen Hospital |
Variants of cpf1 (cas12a) with altered pam specificity
|
AU2018254616B2
(en)
*
|
2017-04-21 |
2022-07-28 |
The General Hospital Corporation |
Inducible, tunable, and multiplex human gene regulation using crispr-Cpf1
|
US11499151B2
(en)
|
2017-04-28 |
2022-11-15 |
Editas Medicine, Inc. |
Methods and systems for analyzing guide RNA molecules
|
CA3062165A1
(en)
*
|
2017-05-04 |
2018-11-08 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for gene editing in t cells using crispr/cpf1
|
EP3634493A1
(en)
|
2017-05-08 |
2020-04-15 |
Precision BioSciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
EP3622092A4
(en)
|
2017-05-11 |
2021-06-23 |
The Broad Institute, Inc. |
Methods and compositions of use of cd8+ tumor infiltrating lymphocyte subtypes and gene signatures thereof
|
WO2018209320A1
(en)
|
2017-05-12 |
2018-11-15 |
President And Fellows Of Harvard College |
Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
|
WO2018213726A1
(en)
|
2017-05-18 |
2018-11-22 |
The Broad Institute, Inc. |
Systems, methods, and compositions for targeted nucleic acid editing
|
AU2018270088B2
(en)
*
|
2017-05-18 |
2024-05-16 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for targeted nucleic acid editing
|
US11046969B2
(en)
|
2017-05-24 |
2021-06-29 |
Epiplanta Biotech Ltd. |
Transgenic plant and the method for producing the same
|
CN110799644A
(zh)
*
|
2017-05-25 |
2020-02-14 |
蓝鸟生物公司 |
Cblb核酸内切酶变体、组合物及使用方法
|
CA3102054A1
(en)
*
|
2017-06-05 |
2018-12-13 |
Fred Hutchinson Cancer Research Center |
Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies
|
CA3064612A1
(en)
|
2017-06-06 |
2018-12-13 |
Zymergen Inc. |
A htp genomic engineering platform for improving escherichia coli
|
CN110719956A
(zh)
|
2017-06-06 |
2020-01-21 |
齐默尔根公司 |
用于改良真菌菌株的高通量基因组工程改造平台
|
CA3065813A1
(en)
|
2017-06-09 |
2018-12-13 |
Editas Medicine, Inc. |
Engineered cas9 nucleases
|
EP3638797A1
(en)
|
2017-06-13 |
2020-04-22 |
Flagship Pioneering Innovations V, Inc. |
Compositions comprising curons and uses thereof
|
US11897953B2
(en)
|
2017-06-14 |
2024-02-13 |
The Broad Institute, Inc. |
Compositions and methods targeting complement component 3 for inhibiting tumor growth
|
CN111511906A
(zh)
*
|
2017-06-23 |
2020-08-07 |
因思科瑞普特公司 |
核酸引导性核酸酶
|
US10011849B1
(en)
*
|
2017-06-23 |
2018-07-03 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
US9982279B1
(en)
|
2017-06-23 |
2018-05-29 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
CN107312790A
(zh)
*
|
2017-06-26 |
2017-11-03 |
中国科学技术大学 |
一种可编程的多位点特异性的转录抑制系统及其应用
|
WO2019005884A1
(en)
|
2017-06-26 |
2019-01-03 |
The Broad Institute, Inc. |
CRISPR / CAS-ADENINE DEAMINASE COMPOSITIONS, SYSTEMS AND METHODS FOR TARGETED NUCLEIC ACID EDITION
|
AU2018291041B2
(en)
|
2017-06-30 |
2021-08-05 |
Inscripta, Inc. |
Automated cell processing methods, modules, instruments, and systems
|
JP2020529834A
(ja)
*
|
2017-06-30 |
2020-10-15 |
プレシジョン バイオサイエンシズ,インク. |
T細胞受容体アルファ遺伝子の改変されたイントロンを含む遺伝子改変t細胞
|
KR102007457B1
(ko)
*
|
2017-06-30 |
2019-08-05 |
동국대학교 산학협력단 |
Cas9 단백질, 가이드 RNA 및 양친매성 펩타이드를 포함하는 나노복합체 및 이의 용도
|
US10392616B2
(en)
|
2017-06-30 |
2019-08-27 |
Arbor Biotechnologies, Inc. |
CRISPR RNA targeting enzymes and systems and uses thereof
|
CN111511375A
(zh)
|
2017-06-30 |
2020-08-07 |
因提玛生物科学公司 |
用于基因治疗的腺相关病毒载体
|
WO2019010422A1
(en)
*
|
2017-07-07 |
2019-01-10 |
The Broad Institute, Inc. |
ANTIVIRAL THERAPY BASED ON THE CRISPR SYSTEM
|
CN112501254B
(zh)
*
|
2017-07-14 |
2024-07-19 |
上海吐露港生物科技有限公司 |
一种Cas蛋白的用途及靶标核酸分子的检测方法和试剂盒
|
US11866726B2
(en)
|
2017-07-14 |
2024-01-09 |
Editas Medicine, Inc. |
Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
|
US12049643B2
(en)
|
2017-07-14 |
2024-07-30 |
The Broad Institute, Inc. |
Methods and compositions for modulating cytotoxic lymphocyte activity
|
US12105089B2
(en)
|
2017-07-17 |
2024-10-01 |
The Broad Institute, Inc. |
Cell atlas of the healthy and ulcerative colitis human colon
|
WO2019018423A1
(en)
*
|
2017-07-17 |
2019-01-24 |
The Broad Institute, Inc. |
NEW TYPE VI CRISPR ORTHOLOGISTS AND ASSOCIATED SYSTEMS
|
WO2019017988A1
(en)
*
|
2017-07-21 |
2019-01-24 |
Arizona Board Of Regents On Behalf Of Arizona State University |
CRISPR FLUORESCENT GUIDED RNA (ARNFG) FOR UNDERSTANDING RNAs EXPRESSED FROM POL II PROMOTERS
|
US11732274B2
(en)
|
2017-07-28 |
2023-08-22 |
President And Fellows Of Harvard College |
Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE)
|
JP7159288B2
(ja)
*
|
2017-07-28 |
2022-10-24 |
ローカス アイピー カンパニー、エルエルシー |
皮膚、毛髪及び頭皮の健康を改善する酵母ベースのマスク
|
US11021719B2
(en)
|
2017-07-31 |
2021-06-01 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for assessing CRISPER/Cas-mediated disruption or excision and CRISPR/Cas-induced recombination with an exogenous donor nucleic acid in vivo
|
BR112019027673A2
(pt)
|
2017-07-31 |
2020-09-15 |
Regeneron Pharmaceuticals, Inc. |
animal não humano, e, métodos para testar a recombinação induzida por crispr/cas e para otimizar a capacidade de crispr/cas
|
CN110891420B
(zh)
|
2017-07-31 |
2022-06-03 |
瑞泽恩制药公司 |
Cas转基因小鼠胚胎干细胞和小鼠及其应用
|
US12215319B2
(en)
|
2017-08-04 |
2025-02-04 |
Syngenta Crop Protection Ag |
Methods and compositions for targeted genomic insertion
|
US10316324B2
(en)
|
2017-08-09 |
2019-06-11 |
Benson Hill Biosystems, Inc. |
Compositions and methods for modifying genomes
|
US11970720B2
(en)
|
2017-08-22 |
2024-04-30 |
Salk Institute For Biological Studies |
RNA targeting methods and compositions
|
US10476825B2
(en)
|
2017-08-22 |
2019-11-12 |
Salk Institue for Biological Studies |
RNA targeting methods and compositions
|
CN111278450B
(zh)
|
2017-08-23 |
2024-04-09 |
通用医疗公司 |
具有改变的PAM特异性的工程化的CRISPR-Cas9核酸酶
|
US10738327B2
(en)
|
2017-08-28 |
2020-08-11 |
Inscripta, Inc. |
Electroporation cuvettes for automation
|
WO2019139645A2
(en)
|
2017-08-30 |
2019-07-18 |
President And Fellows Of Harvard College |
High efficiency base editors comprising gam
|
WO2019046540A1
(en)
*
|
2017-08-31 |
2019-03-07 |
New York Genome Center, Inc. |
METHODS AND COMPOSITIONS COMPRISING CRISPR-CPF1 AND APPROVED GUIDING CRISPR RNAES FOR PROGRAMMABLE GENOMIC DELETIONS
|
AU2018338318B2
(en)
|
2017-09-21 |
2022-12-22 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for targeted nucleic acid editing
|
AU2018338790B2
(en)
|
2017-09-29 |
2022-09-15 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized TTR locus and methods of use
|
US11845951B2
(en)
|
2017-09-29 |
2023-12-19 |
Toolgen Incorporated |
Gene manipulation for treatment of retinal dysfunction disorder
|
AU2018338990B2
(en)
|
2017-09-30 |
2022-06-23 |
Inscripta, Inc. |
Flow through electroporation instrumentation
|
AU2018345539A1
(en)
|
2017-10-03 |
2020-04-16 |
Editas Medicine, Inc. |
HPV-specific binding molecules
|
EP4269560A3
(en)
|
2017-10-03 |
2024-01-17 |
Precision Biosciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
US20190352652A1
(en)
*
|
2017-10-04 |
2019-11-21 |
The Broad Institute, Inc. |
Crispr-systems for modifying a trait of interest in a plant
|
CN111630162A
(zh)
|
2017-10-04 |
2020-09-04 |
博德研究所 |
基于crispr效应系统的诊断
|
AU2018352592B2
(en)
|
2017-10-16 |
2025-03-27 |
Beam Therapeutics, Inc. |
Uses of adenosine base editors
|
BR112020007823A2
(pt)
|
2017-10-20 |
2020-10-27 |
Fred Hutchinson Cancer Research Center |
sistemas e métodos para produzir células b geneticamente modificadas para expressar anticorpos selecionados
|
SG11202003863VA
(en)
|
2017-11-01 |
2020-05-28 |
Univ California |
Casz compositions and methods of use
|
US12227753B2
(en)
|
2017-11-01 |
2025-02-18 |
The Regents Of The University Of California |
CasY compositions and methods of use
|
US11970719B2
(en)
|
2017-11-01 |
2024-04-30 |
The Regents Of The University Of California |
Class 2 CRISPR/Cas compositions and methods of use
|
EP3704238B1
(en)
|
2017-11-01 |
2024-01-03 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
US20200255830A1
(en)
|
2017-11-02 |
2020-08-13 |
Arbor Biotechnologies, Inc. |
Novel crispr-associated transposon systems and components
|
GB2568255A
(en)
*
|
2017-11-08 |
2019-05-15 |
Evox Therapeutics Ltd |
Exosomes comprising RNA therapeutics
|
WO2019094955A1
(en)
|
2017-11-13 |
2019-05-16 |
The Broad Institute, Inc. |
Methods and compositions for targeting developmental and oncogenic programs in h3k27m gliomas
|
WO2019094984A1
(en)
|
2017-11-13 |
2019-05-16 |
The Broad Institute, Inc. |
Methods for determining spatial and temporal gene expression dynamics during adult neurogenesis in single cells
|
US20210180059A1
(en)
|
2017-11-16 |
2021-06-17 |
Astrazeneca Ab |
Compositions and methods for improving the efficacy of cas9-based knock-in strategies
|
KR20200100060A
(ko)
|
2017-11-17 |
2020-08-25 |
이오반스 바이오테라퓨틱스, 인크. |
미세 바늘 흡인물 및 소형 생검물로부터의 til 확장
|
JP2021503885A
(ja)
|
2017-11-22 |
2021-02-15 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
末梢血からの末梢血リンパ球(pbl)の拡大培養
|
US10253365B1
(en)
|
2017-11-22 |
2019-04-09 |
The Regents Of The University Of California |
Type V CRISPR/Cas effector proteins for cleaving ssDNAs and detecting target DNAs
|
WO2019108670A1
(en)
*
|
2017-11-28 |
2019-06-06 |
Emendobio Inc. |
Differential knockout of an allele of a heterozygous fibrinogen alpha chain (fga) gene
|
WO2019113506A1
(en)
|
2017-12-07 |
2019-06-13 |
The Broad Institute, Inc. |
Methods and compositions for multiplexing single cell and single nuclei sequencing
|
US11124798B2
(en)
|
2017-12-08 |
2021-09-21 |
Synthetic Genomics, Inc. |
Algal lipid productivity via genetic modification of a TPR domain containing protein
|
US11203752B2
(en)
*
|
2017-12-11 |
2021-12-21 |
Pioneer Hi-Bred International, Inc. |
Compositions and methods of modifying a plant genome to produce a MS9, MS22, MS26, or MS45 male-sterile plant
|
SG11202003907WA
(en)
|
2017-12-14 |
2020-05-28 |
Flodesign Sonics Inc |
Acoustic transducer drive and controller
|
CA3078682A1
(en)
|
2017-12-15 |
2019-06-20 |
Dana-Farber Cancer Institute, Inc. |
Stabilized peptide-mediated targeted protein degradation
|
US20230193242A1
(en)
*
|
2017-12-22 |
2023-06-22 |
The Broad Institute, Inc. |
Cas12b systems, methods, and compositions for targeted dna base editing
|
WO2019126748A1
(en)
*
|
2017-12-22 |
2019-06-27 |
Fate Therapeutics, Inc. |
Enhanced immune effector cells and use thereof
|
CN111684069A
(zh)
*
|
2017-12-22 |
2020-09-18 |
G+Flas生命科学有限公司 |
嵌合基因组工程分子和方法
|
US11994512B2
(en)
|
2018-01-04 |
2024-05-28 |
Massachusetts Institute Of Technology |
Single-cell genomic methods to generate ex vivo cell systems that recapitulate in vivo biology with improved fidelity
|
WO2019138083A1
(en)
|
2018-01-12 |
2019-07-18 |
Basf Se |
Gene underlying the number of spikelets per spike qtl in wheat on chromosome 7a
|
KR20200103769A
(ko)
*
|
2018-01-23 |
2020-09-02 |
기초과학연구원 |
연장된 단일 가이드 rna 및 그 용도
|
US11926835B1
(en)
|
2018-01-29 |
2024-03-12 |
Inari Agriculture Technology, Inc. |
Methods for efficient tomato genome editing
|
US11220694B1
(en)
*
|
2018-01-29 |
2022-01-11 |
Inari Agriculture, Inc. |
Rice cells and rice plants
|
US20210047653A1
(en)
*
|
2018-01-30 |
2021-02-18 |
The University Of Memphis Research Foundation |
Compositions and methods for regulating a biological process
|
US12275951B2
(en)
*
|
2018-02-06 |
2025-04-15 |
Ohio State Innovation Foundation |
Engineered guide RNA and uses thereof
|
EP3765612A4
(en)
*
|
2018-03-12 |
2022-01-05 |
Nanjing Bioheng Biotech Co., Ltd |
MODIFIED CHEMERICAL GUIDE RNA AND ITS USES
|
ES2953541T3
(es)
|
2018-03-14 |
2023-11-14 |
Arbor Biotechnologies Inc |
Sistemas y enzimas novedosos de direccionamiento a ADN y ARN de CRISPR
|
DK3765615T3
(da)
|
2018-03-14 |
2023-08-21 |
Arbor Biotechnologies Inc |
Nye enzymer og systemer til målretning af crispr dna
|
CN112041433A
(zh)
*
|
2018-03-15 |
2020-12-04 |
Ksq治疗公司 |
用于改进的免疫疗法的基因调控组合物和方法
|
CN108486146B
(zh)
*
|
2018-03-16 |
2021-02-19 |
中国农业科学院作物科学研究所 |
LbCpf1-RR突变体用于CRISPR/Cpf1系统在植物基因编辑中的应用
|
US11519004B2
(en)
|
2018-03-19 |
2022-12-06 |
Regeneran Pharmaceuticals, Inc. |
Transcription modulation in animals using CRISPR/Cas systems
|
EP3546582A1
(en)
|
2018-03-26 |
2019-10-02 |
KWS SAAT SE & Co. KGaA |
Promoter activating elements
|
BR112020019205A2
(pt)
*
|
2018-03-29 |
2021-01-05 |
Fate Therapeutics, Inc. |
Células efetoras imunes geneticamente modificadas e uso das mesmas
|
EP3775159A4
(en)
|
2018-03-29 |
2022-01-19 |
Inscripta, Inc. |
AUTOMATED REGULATION OF CELL GROWTH RATES FOR INDUCTION AND TRANSFORMATION
|
US20210017249A1
(en)
|
2018-04-05 |
2021-01-21 |
Juno Therapeutics, Inc. |
Methods of producing cells expressing a recombinant receptor and related compositions
|
CN112585277A
(zh)
|
2018-04-05 |
2021-03-30 |
朱诺治疗学股份有限公司 |
表达重组受体的t细胞、相关多核苷酸和方法
|
EP4275697A3
(en)
|
2018-04-12 |
2024-01-17 |
Precision BioSciences, Inc. |
Optimized engineered nucleases having specificity for the human t cell receptor alpha constant region gene
|
WO2019200004A1
(en)
|
2018-04-13 |
2019-10-17 |
Inscripta, Inc. |
Automated cell processing instruments comprising reagent cartridges
|
AU2019261361A1
(en)
*
|
2018-04-23 |
2020-11-19 |
Duke University |
Downregulation of SNCA expression by targeted editing of DNA-methylation
|
HUE059223T2
(hu)
|
2018-04-24 |
2022-10-28 |
Kws Saat Se & Co Kgaa |
Jobb emészthetõségû növények és marker haplotípusok
|
US10501738B2
(en)
|
2018-04-24 |
2019-12-10 |
Inscripta, Inc. |
Automated instrumentation for production of peptide libraries
|
US10858761B2
(en)
|
2018-04-24 |
2020-12-08 |
Inscripta, Inc. |
Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells
|
US10526598B2
(en)
|
2018-04-24 |
2020-01-07 |
Inscripta, Inc. |
Methods for identifying T-cell receptor antigens
|
US11957695B2
(en)
|
2018-04-26 |
2024-04-16 |
The Broad Institute, Inc. |
Methods and compositions targeting glucocorticoid signaling for modulating immune responses
|
WO2019210131A1
(en)
|
2018-04-27 |
2019-10-31 |
Iovance Biotherapeutics, Inc. |
Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
CN109678939B
(zh)
*
|
2018-04-27 |
2022-03-04 |
四川大学华西医院 |
一种FnCpf1突变体
|
WO2019217942A1
(en)
|
2018-05-11 |
2019-11-14 |
Beam Therapeutics Inc. |
Methods of substituting pathogenic amino acids using programmable base editor systems
|
US20210198664A1
(en)
|
2018-05-16 |
2021-07-01 |
Arbor Biotechnologies, Inc. |
Novel crispr-associated systems and components
|
WO2019226953A1
(en)
|
2018-05-23 |
2019-11-28 |
The Broad Institute, Inc. |
Base editors and uses thereof
|
EP3802826A1
(en)
*
|
2018-05-24 |
2021-04-14 |
CRISPR Therapeutics AG |
Methods and compositions for efficient gene deletion
|
US20210379105A1
(en)
*
|
2018-05-30 |
2021-12-09 |
The Regents Of The University Of California |
Gene editing of monogenic disorders in human hematopoietic stem cells -- correction of x-linked agammaglobulinemia (xla)
|
EP3575402A1
(en)
*
|
2018-06-01 |
2019-12-04 |
Algentech SAS |
Gene targeting
|
US11866719B1
(en)
|
2018-06-04 |
2024-01-09 |
Inari Agriculture Technology, Inc. |
Heterologous integration of regulatory elements to alter gene expression in wheat cells and wheat plants
|
EP3802806A1
(en)
*
|
2018-06-04 |
2021-04-14 |
University of Copenhagen |
Mutant cpf1 endonucleases
|
BR112020024863A2
(pt)
|
2018-06-05 |
2022-02-01 |
Lifeedit Inc |
Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso
|
AU2019283621B2
(en)
|
2018-06-07 |
2023-03-30 |
Korea Research Institute Of Bioscience And Biotechnology |
Transgenic mouse for aglycosylated antibody production and use of aglycosylated antibody produced therefrom
|
EP3802825A1
(en)
|
2018-06-08 |
2021-04-14 |
Intellia Therapeutics, Inc. |
Compositions and methods for immunooncology
|
US12227776B2
(en)
|
2018-06-13 |
2025-02-18 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
US10227576B1
(en)
|
2018-06-13 |
2019-03-12 |
Caribou Biosciences, Inc. |
Engineered cascade components and cascade complexes
|
US12036240B2
(en)
|
2018-06-14 |
2024-07-16 |
The Broad Institute, Inc. |
Compositions and methods targeting complement component 3 for inhibiting tumor growth
|
BR112020025349A2
(pt)
|
2018-06-15 |
2021-03-09 |
KWS SAAT SE & Co. KGaA |
Métodos para melhorar a engenharia e regeneração do genoma em planta
|
CA3103500A1
(en)
|
2018-06-15 |
2019-12-19 |
KWS SAAT SE & Co. KGaA |
Methods for improving genome engineering and regeneration in plant ii
|
WO2019237380A1
(zh)
*
|
2018-06-16 |
2019-12-19 |
深圳市博奥康生物科技有限公司 |
一种基于慢病毒的 CRISPR/Cpf1 基因编辑载体及其应用
|
WO2019237395A1
(zh)
*
|
2018-06-16 |
2019-12-19 |
深圳市博奥康生物科技有限公司 |
一种应用CRISPR/Cas9系统靶向敲除人CD357基因的方法
|
EP3814520A1
(en)
|
2018-06-26 |
2021-05-05 |
The Broad Institute, Inc. |
Crispr double nickase based amplification compositions, systems, and methods
|
US20210269866A1
(en)
|
2018-06-26 |
2021-09-02 |
The Broad Institute, Inc. |
Crispr effector system based amplification methods, systems, and diagnostics
|
EP3521436A1
(en)
|
2018-06-27 |
2019-08-07 |
VIB vzw |
Complex breeding in plants
|
EP3813974A4
(en)
|
2018-06-30 |
2022-08-03 |
Inscripta, Inc. |
INSTRUMENTS, MODULES AND METHODS FOR ENHANCED DETECTION OF EDITED SEQUENCES IN LIVING CELLS
|
WO2020018142A1
(en)
|
2018-07-16 |
2020-01-23 |
Arbor Biotechnologies, Inc. |
Novel crispr dna targeting enzymes and systems
|
CN113039276A
(zh)
|
2018-07-16 |
2021-06-25 |
密歇根大学董事会 |
核酸酶介导的核酸修饰
|
WO2020028729A1
(en)
|
2018-08-01 |
2020-02-06 |
Mammoth Biosciences, Inc. |
Programmable nuclease compositions and methods of use thereof
|
KR102096592B1
(ko)
*
|
2018-08-09 |
2020-04-02 |
(주)지플러스 생명과학 |
신규한 crispr 연관 단백질 및 이의 용도
|
WO2020030984A2
(en)
*
|
2018-08-09 |
2020-02-13 |
G+Flas Life Sciences |
Compositions and methods for genome engineering with cas12a proteins
|
US11142740B2
(en)
|
2018-08-14 |
2021-10-12 |
Inscripta, Inc. |
Detection of nuclease edited sequences in automated modules and instruments
|
US10532324B1
(en)
|
2018-08-14 |
2020-01-14 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
US10752874B2
(en)
|
2018-08-14 |
2020-08-25 |
Inscripta, Inc. |
Instruments, modules, and methods for improved detection of edited sequences in live cells
|
BR112021003236A2
(pt)
*
|
2018-08-24 |
2021-05-18 |
Flagship Pioneering Innovations Vi, Llc |
métodos e composições para a modificação de plantas
|
AR116016A1
(es)
|
2018-08-24 |
2021-03-25 |
Flagship Pioneering Innovations Vi Llc |
Métodos para fabricar paquetes mensajeros vegetales
|
EP3844263A4
(en)
|
2018-08-30 |
2022-05-25 |
Inscripta, Inc. |
ENHANCED DETECTION OF NUCLEASE-EDITED SEQUENCES IN AUTOMATED MODULES AND INSTRUMENTS
|
US11459551B1
(en)
|
2018-08-31 |
2022-10-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
CN109402115B
(zh)
*
|
2018-09-06 |
2024-02-02 |
广州普世利华科技有限公司 |
靶向Rett突变基因RNA的gRNA及Rett突变基因的检测方法、检测试剂盒
|
US20210317479A1
(en)
*
|
2018-09-06 |
2021-10-14 |
The Broad Institute, Inc. |
Nucleic acid assemblies for use in targeted delivery
|
WO2020049158A1
(en)
|
2018-09-07 |
2020-03-12 |
Astrazeneca Ab |
Compositions and methods for improved nucleases
|
EP4268831A3
(en)
|
2018-09-12 |
2024-05-22 |
Fred Hutchinson Cancer Center |
Reducing cd33 expression to selectively protect therapeutic cells
|
WO2020055941A1
(en)
*
|
2018-09-13 |
2020-03-19 |
Excision Biotherapeutics, Inc. |
Compositions and methods for excision with single grna
|
US11459552B2
(en)
|
2018-09-13 |
2022-10-04 |
The Board Of Regents Of The University Of Oklahoma |
Variant CAS12 proteins with improved dna cleavage selectivity and methods of use
|
BR112021007301A2
(pt)
|
2018-10-18 |
2021-07-27 |
Intellia Therapeutics, Inc. |
composições e métodos para expressar fator ix
|
US11214781B2
(en)
|
2018-10-22 |
2022-01-04 |
Inscripta, Inc. |
Engineered enzyme
|
US10604746B1
(en)
|
2018-10-22 |
2020-03-31 |
Inscripta, Inc. |
Engineered enzymes
|
CN111100876A
(zh)
*
|
2018-10-25 |
2020-05-05 |
立沃生物科技(深圳)有限公司 |
CRISPR-Cas9特异性敲除FAH基因的方法及特异性sgRNA
|
US11407995B1
(en)
|
2018-10-26 |
2022-08-09 |
Inari Agriculture Technology, Inc. |
RNA-guided nucleases and DNA binding proteins
|
US12281338B2
(en)
|
2018-10-29 |
2025-04-22 |
The Broad Institute, Inc. |
Nucleobase editors comprising GeoCas9 and uses thereof
|
WO2020092057A1
(en)
|
2018-10-30 |
2020-05-07 |
Yale University |
Compositions and methods for rapid and modular generation of chimeric antigen receptor t cells
|
JP2022513408A
(ja)
|
2018-10-31 |
2022-02-07 |
ザイマージェン インコーポレイテッド |
Dnaライブラリーの多重化決定論的アセンブリー
|
US20220333089A1
(en)
*
|
2018-11-01 |
2022-10-20 |
The University Of Tokyo |
Split CPF1 Protein
|
US11434477B1
(en)
|
2018-11-02 |
2022-09-06 |
Inari Agriculture Technology, Inc. |
RNA-guided nucleases and DNA binding proteins
|
JP2022506508A
(ja)
|
2018-11-05 |
2022-01-17 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
Akt経路阻害剤を利用したtilの拡大培養
|
CN113272420A
(zh)
|
2018-11-05 |
2021-08-17 |
艾欧凡斯生物治疗公司 |
经改进的肿瘤反应性t细胞的选择
|
US20220090018A1
(en)
|
2018-11-05 |
2022-03-24 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and used of the same in immunotherapy
|
CN112969469A
(zh)
|
2018-11-05 |
2021-06-15 |
艾欧凡斯生物治疗公司 |
抗pd-1抗体难治性nsclc患者的治疗
|
CA3119065A1
(en)
*
|
2018-11-07 |
2020-05-14 |
Akouos, Inc. |
Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
|
CN109385451B
(zh)
*
|
2018-11-07 |
2020-07-07 |
中国海洋大学 |
一种牡蛎CRISPR/Cas9基因编辑方法
|
US11884925B2
(en)
*
|
2018-11-08 |
2024-01-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Synthetic immunomodulation with a CRISPR super-repressor in vivo
|
US12165743B2
(en)
|
2018-11-09 |
2024-12-10 |
The Broad Institute, Inc. |
Compressed sensing for screening and tissue imaging
|
SG11202105083XA
(en)
*
|
2018-11-14 |
2021-06-29 |
Broad Inst Inc |
Crispr system based droplet diagnostic systems and methods
|
CN113462672A
(zh)
*
|
2018-11-15 |
2021-10-01 |
中国农业大学 |
CRISPR-Cas12j酶和系统
|
WO2020098793A1
(zh)
*
|
2018-11-15 |
2020-05-22 |
中国农业大学 |
CRISPR-Cas12a酶和系统
|
CN109536506B
(zh)
*
|
2018-12-10 |
2022-03-22 |
潍坊科技学院 |
一种调控日本沼虾生长发育的类胰岛素受体基因及其应用
|
CN109593743A
(zh)
*
|
2018-12-12 |
2019-04-09 |
广州普世利华科技有限公司 |
新型CRISPR/ScCas12a蛋白及其制备方法
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
CN109680053A
(zh)
*
|
2018-12-12 |
2019-04-26 |
广州普世利华科技有限公司 |
新型SsCas12a蛋白在核酸检测方面的应用
|
CN109666662A
(zh)
*
|
2018-12-12 |
2019-04-23 |
广州普世利华科技有限公司 |
新型ScCas12a在核酸检测方面的应用
|
US20250043366A1
(en)
|
2018-12-13 |
2025-02-06 |
The Broad Institute, Inc. |
Tiled assays using crispr-cas based detection
|
US12264323B2
(en)
|
2018-12-17 |
2025-04-01 |
The Broad Institute, Inc. |
CRISPR CPF1 direct repeat variants
|
CN113544266A
(zh)
|
2018-12-17 |
2021-10-22 |
博德研究所 |
Crispr相关转座酶系统和其使用方法
|
EP3898949A1
(en)
|
2018-12-19 |
2021-10-27 |
Iovance Biotherapeutics, Inc. |
Methods of expanding tumor infiltrating lymphocytes using engineered cytokine receptor pairs and uses thereof
|
EP3732291A1
(en)
|
2018-12-20 |
2020-11-04 |
Regeneron Pharmaceuticals, Inc. |
Nuclease-mediated repeat expansion
|
US20220090047A1
(en)
|
2018-12-21 |
2022-03-24 |
Precision Biosciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
JP7572360B2
(ja)
|
2018-12-27 |
2024-10-23 |
ライフエディット セラピューティクス,インコーポレイティド |
遺伝子編集に有用なポリペプチドと利用方法
|
WO2020142754A2
(en)
|
2019-01-04 |
2020-07-09 |
Mammoth Biosciences, Inc. |
Programmable nuclease improvements and compositions and methods for nucleic acid amplification and detection
|
US11739156B2
(en)
|
2019-01-06 |
2023-08-29 |
The Broad Institute, Inc. Massachusetts Institute of Technology |
Methods and compositions for overcoming immunosuppression
|
CN109799295A
(zh)
*
|
2019-01-28 |
2019-05-24 |
江南大学 |
一种用于秀丽隐杆线虫代谢组学分析的样品前处理方法
|
US20220145330A1
(en)
|
2019-02-10 |
2022-05-12 |
The J. David Gladstone Institutes, a testamentary trust established under the Will of J. David Glads |
Modified mitochondrion and methods of use thereof
|
JP2022520783A
(ja)
|
2019-02-12 |
2022-04-01 |
ウニヴェルシタ デリ ストゥディ ディ トレント |
Cas12aガイドRNA分子およびその使用
|
CN114096666B
(zh)
|
2019-02-13 |
2025-03-18 |
比姆医疗股份有限公司 |
治疗血红素病变的组合物和方法
|
WO2020168075A1
(en)
*
|
2019-02-13 |
2020-08-20 |
Beam Therapeutics Inc. |
Splice acceptor site disruption of a disease-associated gene using adenosine deaminase base editors, including for the treatment of genetic disease
|
JP7390385B2
(ja)
*
|
2019-02-13 |
2023-12-01 |
プロバイオジェン アーゲー |
挿入部位選択特性が向上したトランスポザーゼ
|
JP7608348B2
(ja)
*
|
2019-02-15 |
2025-01-06 |
アレン インスティテュート |
選択されたニューロン細胞集団における遺伝子発現を選択的に調節するための人工発現コンストラクト
|
CA3130087A1
(en)
|
2019-02-22 |
2020-08-27 |
Integrated Dna Technologies, Inc. |
Lachnospiraceae bacterium nd2006 cas12a mutant genes and polypeptides encoded by same
|
CN109975543B
(zh)
*
|
2019-03-01 |
2022-02-11 |
中国疾病预防控制中心传染病预防控制所 |
分枝杆菌Ku蛋白的应用
|
AU2020233284A1
(en)
|
2019-03-01 |
2021-09-16 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
WO2020185590A1
(en)
|
2019-03-08 |
2020-09-17 |
Zymergen Inc. |
Iterative genome editing in microbes
|
US11053515B2
(en)
|
2019-03-08 |
2021-07-06 |
Zymergen Inc. |
Pooled genome editing in microbes
|
EP3938510A1
(en)
|
2019-03-11 |
2022-01-19 |
Sorrento Therapeutics, Inc. |
Improved process for integration of dna constructs using rna-guided endonucleases
|
WO2020186231A2
(en)
|
2019-03-14 |
2020-09-17 |
The Broad Institute, Inc. |
Crispr effector system based multiplex diagnostics
|
CA3127814C
(en)
|
2019-03-18 |
2024-05-14 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas dropout screening platform to reveal genetic vulnerabilities associated with tau aggregation
|
SG11202108091YA
(en)
|
2019-03-18 |
2021-08-30 |
Regeneron Pharma |
Crispr/cas screening platform to identify genetic modifiers of tau seeding or aggregation
|
JP7669281B2
(ja)
|
2019-03-19 |
2025-04-28 |
ザ ブロード インスティテュート,インコーポレーテッド |
編集ヌクレオチド配列を編集するための方法および組成物
|
WO2020198174A1
(en)
|
2019-03-25 |
2020-10-01 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
US11001831B2
(en)
|
2019-03-25 |
2021-05-11 |
Inscripta, Inc. |
Simultaneous multiplex genome editing in yeast
|
EP3947682B1
(en)
|
2019-04-03 |
2023-10-11 |
Precision Biosciences, Inc. |
Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)
|
WO2020206162A1
(en)
|
2019-04-03 |
2020-10-08 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for insertion of antibody coding sequences into a safe harbor locus
|
RU2771374C1
(ru)
|
2019-04-04 |
2022-05-04 |
Редженерон Фармасьютикалс, Инк. |
Способы для бесшовного внесения целевых модификаций в направленные векторы
|
IL286905B2
(en)
|
2019-04-04 |
2024-06-01 |
Regeneron Pharma |
Non-human animals containing the human coagulation factor 12 locus
|
EP3947646A1
(en)
|
2019-04-05 |
2022-02-09 |
Precision BioSciences, Inc. |
Methods of preparing populations of genetically-modified immune cells
|
BR112021019657A2
(pt)
|
2019-04-05 |
2021-11-30 |
Univ Osaka |
Método para produzir célula knock-in
|
CN110396543A
(zh)
*
|
2019-04-30 |
2019-11-01 |
广州普世利华科技有限公司 |
一种肿瘤相关基因突变位点筛查方法
|
CN110195102A
(zh)
*
|
2019-04-30 |
2019-09-03 |
广州普世利华科技有限公司 |
一种β地中海贫血基因分型方法
|
CA3138329A1
(en)
|
2019-05-10 |
2020-11-19 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
WO2020232029A1
(en)
|
2019-05-13 |
2020-11-19 |
Iovance Biotherapeutics, Inc. |
Methods and compositions for selecting tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
US20220243287A1
(en)
|
2019-05-13 |
2022-08-04 |
KWS SAAT SE & Co. KGaA |
Drought tolerance in corn
|
CN114703142B
(zh)
*
|
2019-05-16 |
2024-05-10 |
上海苹谱医疗科技有限公司 |
一种人诱导多潜能干细胞、构建方法及其用途
|
US20220220469A1
(en)
*
|
2019-05-20 |
2022-07-14 |
The Broad Institute, Inc. |
Non-class i multi-component nucleic acid targeting systems
|
AU2020278906A1
(en)
|
2019-05-23 |
2021-11-25 |
Nomad Bioscience Gmbh |
RNA viral RNA molecule for gene editing
|
AR118995A1
(es)
|
2019-05-25 |
2021-11-17 |
Kws Saat Se & Co Kgaa |
Mejorador de la inducción de haploides
|
MA56037A
(fr)
*
|
2019-05-28 |
2022-04-06 |
Octant Inc |
Système de relais de transcription
|
EP3801011A1
(en)
|
2019-06-04 |
2021-04-14 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
|
AU2020288623A1
(en)
|
2019-06-06 |
2022-01-06 |
Inscripta, Inc. |
Curing for recursive nucleic acid-guided cell editing
|
AU2020289581B2
(en)
|
2019-06-07 |
2024-11-21 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized albumin locus
|
PH12021553076A1
(en)
|
2019-06-07 |
2023-08-14 |
Scribe Therapeutics Inc |
Engineered casx systems
|
MX2021015335A
(es)
|
2019-06-13 |
2022-01-18 |
Nunhems Bv |
Planta de tomate que produce frutas que tienen caracteristicas mejoradas de maduracion.
|
AU2020290509B2
(en)
*
|
2019-06-14 |
2024-11-28 |
Regeneron Pharmaceuticals, Inc. |
Models of tauopathy
|
US10907125B2
(en)
|
2019-06-20 |
2021-02-02 |
Inscripta, Inc. |
Flow through electroporation modules and instrumentation
|
AU2020297499A1
(en)
|
2019-06-21 |
2022-02-03 |
Inscripta, Inc. |
Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli
|
US10927385B2
(en)
|
2019-06-25 |
2021-02-23 |
Inscripta, Inc. |
Increased nucleic-acid guided cell editing in yeast
|
CA3138663A1
(en)
|
2019-06-25 |
2020-12-30 |
Inari Agriculture Technology, Inc. |
Improved homology dependent repair genome editing
|
CN112168808B
(zh)
*
|
2019-07-02 |
2023-01-24 |
深圳市第二人民医院 |
一种基于crispr的细胞核靶向药物递送系统
|
SG11202111943UA
(en)
|
2019-07-02 |
2021-11-29 |
Hutchinson Fred Cancer Res |
Recombinant ad35 vectors and related gene therapy improvements
|
CA3144106A1
(en)
|
2019-07-03 |
2021-01-07 |
Integrated Dna Technologies, Inc. |
Identification, characterization, and quantitation of crispr-introduced double-stranded dna break repairs
|
EP3993612A1
(en)
|
2019-07-05 |
2022-05-11 |
Limagrain Europe |
Method for increasing yield in plants
|
CA3146967A1
(en)
*
|
2019-07-17 |
2021-01-21 |
Fate Therapeutics, Inc. |
Immune effector cell engineering and use thereof
|
EP4004216A1
(en)
|
2019-07-25 |
2022-06-01 |
Precision BioSciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
US20220364159A1
(en)
*
|
2019-07-26 |
2022-11-17 |
Mammoth Biosciences, Inc. |
Compositions for detection of dna and methods of use thereof
|
CN110358767B
(zh)
*
|
2019-07-30 |
2021-06-08 |
湖北大学 |
一种基于CRISPR-Cas12a系统的运动发酵单胞菌基因组编辑方法及其应用
|
AU2020324386A1
(en)
*
|
2019-08-02 |
2022-02-24 |
Monsanto Technology Llc |
Methods and compositions to promote targeted genome modifications using HUH endonucleases
|
EP3772542A1
(en)
|
2019-08-07 |
2021-02-10 |
KWS SAAT SE & Co. KGaA |
Modifying genetic variation in crops by modulating the pachytene checkpoint protein 2
|
WO2021028359A1
(en)
|
2019-08-09 |
2021-02-18 |
Sangamo Therapeutics France |
Controlled expression of chimeric antigen receptors in t cells
|
TW202120688A
(zh)
|
2019-08-12 |
2021-06-01 |
美商生命編輯公司 |
Rna導引之核酸酶及其活性片段及變體以及使用方法
|
CN110592014A
(zh)
*
|
2019-08-14 |
2019-12-20 |
广东美赛尔细胞生物科技有限公司 |
一种在nk细胞治疗中免辐照体外体内持续去除饲养细胞的方法
|
EP4047087A4
(en)
*
|
2019-08-19 |
2023-08-23 |
Southern Medical University |
Construction of high-fidelity crispr/ascpf1 mutant and application thereof
|
CA3148179A1
(en)
|
2019-08-20 |
2021-02-25 |
Bruce J. Mccreedy Jr. |
Lymphodepletion dosing regimens for cellular immunotherapies
|
WO2021035170A1
(en)
|
2019-08-21 |
2021-02-25 |
Precision Biosciences, Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
CN112442515B
(zh)
*
|
2019-09-02 |
2023-01-10 |
南京启真基因工程有限公司 |
gRNA靶点组合在构建血友病模型猪细胞系中的应用
|
US20220333208A1
(en)
|
2019-09-03 |
2022-10-20 |
The Broad Institute, Inc. |
Crispr effector system based multiplex cancer diagnostics
|
AU2020341711A1
(en)
*
|
2019-09-05 |
2022-03-03 |
Arbor Biotechnologies, Inc. |
Novel CRISPR DNA targeting enzymes and systems
|
WO2021046526A1
(en)
|
2019-09-05 |
2021-03-11 |
Benson Hill, Inc. |
Compositions and methods for modifying genomes
|
US20240169179A2
(en)
|
2019-09-10 |
2024-05-23 |
Science Solutions Llc |
Novel class 2 type ii and type v crispr-cas rna-guided endonucleases
|
CN110628816B
(zh)
*
|
2019-09-12 |
2022-10-18 |
中国医学科学院血液病医院(中国医学科学院血液学研究所) |
一种用于血友病a的双切供体及其药物组合
|
CA3150334A1
(en)
|
2019-09-12 |
2021-03-18 |
Frank Meulewaeter |
REGULATORY NUCLEIC ACID MOLECULES TO ENHANCE GENE EXPRESSION IN PLANTS
|
CA3153980A1
(en)
|
2019-09-13 |
2021-03-18 |
Regeneron Pharmaceuticals, Inc. |
Transcription modulation in animals using crispr/cas systems delivered by lipid nanoparticles
|
CN110600083B
(zh)
*
|
2019-09-20 |
2020-05-19 |
中国人民解放军军事科学院军事医学研究院 |
基于无拼接组装wgs数据的醋酸钙—鲍曼不动杆菌复合群鉴定方法
|
CA3147641A1
(en)
|
2019-09-23 |
2021-04-01 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating apolipoprotein b (apob) gene expression
|
JP2022548399A
(ja)
|
2019-09-23 |
2022-11-18 |
オメガ セラピューティクス, インコーポレイテッド |
肝細胞核因子4-アルファ(HNF4α)遺伝子発現をモジュレートするための組成物および方法
|
JP2022550599A
(ja)
*
|
2019-10-03 |
2022-12-02 |
アーティサン ディベロップメント ラブズ インコーポレイテッド |
操作されたデュアルガイド核酸を有するcrisprシステム
|
WO2021069387A1
(en)
|
2019-10-07 |
2021-04-15 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
IL292117A
(en)
*
|
2019-10-17 |
2022-06-01 |
Pairwise Plants Services Inc |
Variants of cas12a nucleases and methods of making and use thereof
|
CN114846022A
(zh)
|
2019-10-17 |
2022-08-02 |
科沃施种子欧洲股份两合公司 |
通过阻抑基因的下调增强作物的疾病抗性
|
WO2021081384A1
(en)
*
|
2019-10-25 |
2021-04-29 |
Greenvenus, Llc |
Synthetic nucleases
|
WO2021081378A1
(en)
|
2019-10-25 |
2021-04-29 |
Iovance Biotherapeutics, Inc. |
Gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy
|
US11844800B2
(en)
|
2019-10-30 |
2023-12-19 |
Massachusetts Institute Of Technology |
Methods and compositions for predicting and preventing relapse of acute lymphoblastic leukemia
|
US20220411479A1
(en)
|
2019-10-30 |
2022-12-29 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
CA3158897A1
(en)
|
2019-10-30 |
2021-05-06 |
Pairwise Plants Services, Inc. |
Type v crispr-cas base editors and methods of use thereof
|
JP2023505600A
(ja)
|
2019-11-05 |
2023-02-09 |
ペアーワイズ プランツ サービシズ, インコーポレイテッド |
対立遺伝子のrnaにコードされたdnaの置換のための組成物および方法
|
AU2020379046B2
(en)
|
2019-11-08 |
2025-03-13 |
Regeneron Pharmaceuticals, Inc. |
CRISPR and AAV strategies for X-linked juvenile retinoschisis therapy
|
CN115052980B
(zh)
*
|
2019-11-18 |
2024-09-10 |
苏州齐禾生科生物科技有限公司 |
衍生自黄杆菌的基因编辑系统
|
US11203762B2
(en)
|
2019-11-19 |
2021-12-21 |
Inscripta, Inc. |
Methods for increasing observed editing in bacteria
|
CN110760597B
(zh)
*
|
2019-11-22 |
2022-08-23 |
西北农林科技大学 |
一种检测黄牛ncstn基因拷贝数变异的方法及其应用
|
WO2021108363A1
(en)
|
2019-11-25 |
2021-06-03 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-mediated upregulation of humanized ttr allele
|
WO2021108324A1
(en)
*
|
2019-11-27 |
2021-06-03 |
Technical University Of Denmark |
Constructs, compositions and methods thereof having improved genome editing efficiency and specificity
|
EP4064830A1
(en)
|
2019-11-29 |
2022-10-05 |
Basf Se |
Increasing resistance against fungal infections in plants
|
AU2020396138A1
(en)
|
2019-12-03 |
2022-06-16 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
WO2021113522A1
(en)
*
|
2019-12-04 |
2021-06-10 |
Arbor Biotechnologies, Inc. |
Compositions comprising a nuclease and uses thereof
|
WO2021113788A1
(en)
*
|
2019-12-06 |
2021-06-10 |
Pairwise Plants Services, Inc. |
Recruitment methods and compounds, compositions and systems for recruitment
|
US20230036065A1
(en)
|
2019-12-06 |
2023-02-02 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
CN118638870A
(zh)
|
2019-12-10 |
2024-09-13 |
因思科瑞普特公司 |
新颖的mad核酸酶
|
US20230220341A1
(en)
|
2019-12-11 |
2023-07-13 |
lovance Biotherapeutics, Inc. |
Processes for the production of tumor infiltrating lymphocytes (tils) and methods of using the same
|
CN110791523B
(zh)
*
|
2019-12-13 |
2022-05-10 |
南京农业大学 |
一种棉花抗旱相关基因GhRCHY1及其应用
|
KR102493904B1
(ko)
*
|
2019-12-13 |
2023-01-31 |
한국생명공학연구원 |
EeCpf1에 의해 IL2Rg 유전자가 돌연변이된 면역부전 동물모델 및 그 제조방법
|
RU2720768C1
(ru)
*
|
2019-12-13 |
2020-05-13 |
Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) |
Система CRISPR-Cas для детекции провирусной ДНК вируса иммунодефицита человека, интегрированной в геном человека, в ультранизких концентрациях
|
US10704033B1
(en)
|
2019-12-13 |
2020-07-07 |
Inscripta, Inc. |
Nucleic acid-guided nucleases
|
RU2720769C1
(ru)
*
|
2019-12-13 |
2020-05-13 |
Федеральное бюджетное учреждение науки «Центральный научно-исследовательский институт эпидемиологии» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) |
Способ получения препарата рибонуклеопротеинового комплекса CRISPR/CAS и препарат для детекции провирусной ДНК вируса иммунодефицита человека, интегрированной в геном человека, в ультранизких концентрациях
|
RU2720767C1
(ru)
*
|
2019-12-13 |
2020-05-13 |
Федеральное бюджетное учреждение науки «Центральный научно-исследовательский институт эпидемиологии» Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) |
Способ обнаружения провирусной ДНК вируса иммунодефицита человека, интегрированной в геном человека, в ультранизких концентрациях и специфические олигонуклеотиды для использования в способе
|
KR20220116173A
(ko)
|
2019-12-16 |
2022-08-22 |
바스프 아그리컬쳐럴 솔루션즈 시드 유에스 엘엘씨 |
밀의 게놈에의 dna 또는 돌연변이의 정확한 도입
|
KR20220116485A
(ko)
|
2019-12-16 |
2022-08-23 |
바스프 아그리컬쳐럴 솔루션즈 시드 유에스 엘엘씨 |
쌍을 형성한 닉카제를 이용하는 개선된 게놈 편집
|
CN114829607A
(zh)
|
2019-12-18 |
2022-07-29 |
因思科瑞普特公司 |
用于体内检测核酸引导的核酸酶编辑的细胞的Cascade/dCas3互补测定
|
WO2021122687A1
(en)
|
2019-12-19 |
2021-06-24 |
Basf Se |
Increasing space-time-yield, carbon-conversion-efficiency and carbon substrate flexibility in the production of fine chemicals
|
MX2022007714A
(es)
|
2019-12-20 |
2022-07-19 |
Basf Se |
Disminucion de la toxicidad de terpenos y aumento de la posible produccion en microorganismos.
|
CN115190912A
(zh)
|
2019-12-30 |
2022-10-14 |
生命编辑制药股份有限公司 |
Rna指导核酸酶及其活性片段与变体以及使用方法
|
CN111073902B
(zh)
*
|
2019-12-30 |
2022-04-26 |
广东省微生物研究所(广东省微生物分析检测中心) |
提升胶霉毒素生物合成基因表达水平的CRISPR/dCas9载体及其构建方法和应用
|
CN113073118B
(zh)
*
|
2020-01-03 |
2023-09-15 |
珠海联邦制药股份有限公司 |
Tet-off表达调控系统在级联放大启动子活性中的用途
|
KR20220125304A
(ko)
|
2020-01-06 |
2022-09-14 |
페어와이즈 플랜츠 서비시즈, 인크. |
주형화된 편집을 위한 dna 폴리머라제의 동원
|
US10689669B1
(en)
|
2020-01-11 |
2020-06-23 |
Inscripta, Inc. |
Automated multi-module cell processing methods, instruments, and systems
|
WO2021146641A1
(en)
|
2020-01-17 |
2021-07-22 |
The Broad Institute, Inc. |
Small type ii-d cas proteins and methods of use thereof
|
CA3168604A1
(en)
|
2020-01-21 |
2021-07-29 |
Limagrain Europe |
Wheat haploid inducer plant and uses
|
US12264341B2
(en)
|
2020-01-24 |
2025-04-01 |
The General Hospital Corporation |
CRISPR-Cas enzymes with enhanced on-target activity
|
EP4093907A4
(en)
*
|
2020-01-24 |
2024-01-17 |
The General Hospital Corporation |
METHOD FOR CHARACTERIZING ENZYMES FOR GENOME ENGINEERING
|
EP4096770A1
(en)
|
2020-01-27 |
2022-12-07 |
Inscripta, Inc. |
Electroporation modules and instrumentation
|
AU2021212189A1
(en)
|
2020-01-30 |
2022-08-04 |
Pairwise Plants Services, Inc. |
Compositions, systems, and methods for base diversification
|
UY39058A
(es)
|
2020-01-31 |
2021-08-31 |
Pairwise Plants Services Inc |
Suppresión de la respuesta de evasión a la sombra en plantas
|
WO2021158798A1
(en)
|
2020-02-04 |
2021-08-12 |
Pairwise Plants Services, Inc. |
Thornless / prickleless rubus plants
|
CN111337666B
(zh)
*
|
2020-02-12 |
2021-04-02 |
山东大学 |
I-motif重组介导的FRET探针及其原位成像癌细胞表面蛋白质同源二聚化的应用
|
CN113261532A
(zh)
*
|
2020-02-17 |
2021-08-17 |
中山大学 |
一种肺癌动物模型的构建方法
|
WO2021165508A1
(en)
|
2020-02-21 |
2021-08-26 |
Biogemma |
Prime editing technology for plant genome engineering
|
WO2021168288A1
(en)
|
2020-02-21 |
2021-08-26 |
Pairwise Plants Services, Inc. |
Improved resistance to soybean cyst nematode through gene editing
|
US20230183377A1
(en)
|
2020-02-26 |
2023-06-15 |
Sorrento Therapeutics, Inc. |
Activatable antigen binding proteins with universal masking moieties
|
US12012433B1
(en)
|
2020-02-27 |
2024-06-18 |
Integrated Dna Technologies Inc. |
Expression and purification of Cas enzymes
|
US20240191248A1
(en)
|
2020-02-28 |
2024-06-13 |
KWS SAAT SE & Co. KGaA |
Method for rapid genome modification in recalcitrant plants
|
CA3169128A1
(en)
|
2020-02-28 |
2021-09-02 |
Ling MENG |
Immature inflorescence meristem editing
|
KR102647294B1
(ko)
*
|
2020-02-28 |
2024-03-13 |
후이진 테라퓨틱스 씨오., 엘티디. |
유형 VI-E 및 유형 VI-F CRISPR-Cas 시스템 및 이의 용도
|
JP2023515671A
(ja)
|
2020-03-04 |
2023-04-13 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
免疫療法に対する腫瘍細胞の感作のための方法及び組成物
|
KR20240036729A
(ko)
*
|
2020-03-06 |
2024-03-20 |
메타지노미, 인크. |
클래스 ii, 타입 v crispr 시스템
|
AU2021234302A1
(en)
|
2020-03-11 |
2022-11-10 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating forkhead box p3 (foxp3) gene expression
|
EP3878958A1
(en)
|
2020-03-11 |
2021-09-15 |
B.R.A.I.N. Biotechnology Research And Information Network AG |
Crispr-cas nucleases from cpr-enriched metagenome
|
EP4121532A4
(en)
|
2020-03-17 |
2024-03-13 |
The Broad Institute, Inc. |
HIGH-THROUGHPUT CRISPR SYSTEM, DIAGNOSTIC SYSTEMS AND METHODS
|
WO2021195079A1
(en)
|
2020-03-23 |
2021-09-30 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals comprising a humanized ttr locus comprising a v30m mutation and methods of use
|
US11999946B2
(en)
|
2020-03-26 |
2024-06-04 |
Pairwise Plants Services, Inc. |
Methods for controlling meristem size for crop improvement
|
US11882808B2
(en)
|
2020-03-27 |
2024-01-30 |
Pairwise Plants Services, Inc. |
Methods for improving resistance to soybean rust
|
CN115697044A
(zh)
|
2020-03-31 |
2023-02-03 |
艾洛生物系统有限公司 |
西瓜和其他葫芦科中内源罗汉果苷途径基因的调控
|
WO2021207148A1
(en)
|
2020-04-06 |
2021-10-14 |
Pairwise Plants Services, Inc. |
Methods and compositions for increasing resistance to ear rot and stem rot disease in maize
|
EP4133069A2
(en)
|
2020-04-08 |
2023-02-15 |
Astrazeneca AB |
Compositions and methods for improved site-specific modification
|
RU2743861C1
(ru)
*
|
2020-04-15 |
2021-03-01 |
Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) |
Система CRISPR-Cas для выявления гена антибиотикоустойчивости blaVIM-2 (металло-бета-лактамаза класс B VIM-2) Pseudomonas aeruginosa в ультранизких концентрациях
|
RU2745637C1
(ru)
*
|
2020-04-15 |
2021-03-29 |
Федеральное бюджетное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека (ФБУН ЦНИИ Эпидемиологии Роспотребнадзора) |
Способ получения препарата рибонуклеопротеинового комплекса CRISPR/Cas и препарат для выявления гена антибиотикоустойчивости bla VIM-2 (металло-бета-лактамаза класс B VIM-2) Pseudomonas aeruginosa в ультранизких концентрациях
|
US20230212600A1
(en)
|
2020-04-16 |
2023-07-06 |
Pairwise Plants Services, Inc. |
Methods for controlling meristem size for crop improvement
|
TW202208626A
(zh)
|
2020-04-24 |
2022-03-01 |
美商生命編輯公司 |
Rna引導核酸酶及其活性片段與變體,以及使用方法
|
US20210332388A1
(en)
|
2020-04-24 |
2021-10-28 |
Inscripta, Inc. |
Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells
|
WO2021217083A1
(en)
|
2020-04-24 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Memory dimeric antigen receptors
|
WO2021222703A2
(en)
|
2020-05-01 |
2021-11-04 |
Integrated Dna Technologies, Inc. |
Lachnospiraceae sp. cas12a mutants with enhanced cleavage activity at non-canonical tttt protospacer adjacent motifs
|
US20230172987A1
(en)
|
2020-05-04 |
2023-06-08 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes and uses of the same in immunotherapy
|
CN116096873A
(zh)
|
2020-05-08 |
2023-05-09 |
布罗德研究所股份有限公司 |
同时编辑靶标双链核苷酸序列的两条链的方法和组合物
|
WO2021224506A1
(en)
*
|
2020-05-08 |
2021-11-11 |
Universitat Pompeu Fabra |
Crispr-cas homology directed repair enhancer
|
WO2021231259A1
(en)
|
2020-05-11 |
2021-11-18 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
US20230183725A1
(en)
|
2020-05-13 |
2023-06-15 |
Nunhems B.V. |
Method for obtaining mutant plants by targeted mutagenesis
|
CA3178083A1
(en)
|
2020-05-13 |
2021-11-18 |
Wim VRIEZEN |
Tomato plants having suppressed meiotic recombination
|
US11787841B2
(en)
|
2020-05-19 |
2023-10-17 |
Inscripta, Inc. |
Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli
|
WO2021243283A1
(en)
*
|
2020-05-28 |
2021-12-02 |
University Of Southern California |
Scalable trio guide rna approach for integration of large donor dna
|
AR122206A1
(es)
|
2020-05-29 |
2022-08-24 |
Kws Saat Se & Co Kgaa |
Inducción de haploides en plantas
|
WO2021247477A1
(en)
|
2020-06-02 |
2021-12-09 |
Pairwise Plants Services, Inc. |
Methods for controlling meristem size for crop improvement
|
CN116209755A
(zh)
*
|
2020-06-03 |
2023-06-02 |
猛犸生物科学公司 |
可编程核酸酶和使用方法
|
CN111808832B
(zh)
*
|
2020-06-05 |
2022-02-11 |
华南农业大学 |
一种水稻纹枯病菌阳离子转运ATP酶基因及其片段Rscta和应用
|
JP7419168B2
(ja)
*
|
2020-06-10 |
2024-01-22 |
株式会社東芝 |
改変型piggyBacトランスポゼースのポリペプチド、それをコードするポリヌクレオチド、導入キャリア、キット、細胞のゲノムに目的配列を組込む方法及び細胞製造方法
|
CA3186580A1
(en)
|
2020-06-12 |
2021-12-16 |
Sherlock Biosciences, Inc. |
Crispr-based sars-cov-2 detection
|
UY39278A
(es)
|
2020-06-17 |
2022-01-31 |
Pairwise Plants Services Inc |
Métodos para el control del tamaño del meristemo para la mejora de cultivos
|
KR20230042283A
(ko)
|
2020-06-26 |
2023-03-28 |
주노 테라퓨틱스 게엠베하 |
재조합 수용체를 조건부로 발현하는 조작된 t 세포, 관련된 폴리뉴클레오티드 및 방법
|
US20230348920A1
(en)
|
2020-06-29 |
2023-11-02 |
KWS SAAT SE & Co. KGaA |
Boosting homology directed repair in plants
|
WO2022006226A1
(en)
|
2020-06-30 |
2022-01-06 |
Pairwise Plants Services, Inc. |
Compositions, systems, and methods for base diversification
|
JP2023534693A
(ja)
|
2020-07-15 |
2023-08-10 |
ライフエディット セラピューティクス,インコーポレイティド |
ウラシル安定化タンパク質並びにその活性断片及びバリアント並びに使用方法
|
CN111778252B
(zh)
*
|
2020-07-17 |
2022-01-07 |
湖北省农业科学院畜牧兽医研究所 |
一种靶向敲除SST基因的sgRNA及其CRISPR/Cas9系统和应用
|
JP2023536408A
(ja)
|
2020-07-21 |
2023-08-25 |
ペアワイズ・プランツ・サーヴィシズ,インコーポレイテッド |
最適化されたタンパク質リンカーおよび使用方法
|
EP3943600A1
(en)
|
2020-07-21 |
2022-01-26 |
B.R.A.I.N. Biotechnology Research And Information Network AG |
Novel, non-naturally occurring crispr-cas nucleases for genome editing
|
WO2022032195A2
(en)
*
|
2020-08-06 |
2022-02-10 |
Singular Genomics Systems, Inc. |
Spatial sequencing
|
EP4192875A1
(en)
|
2020-08-10 |
2023-06-14 |
Precision BioSciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
JP2023538303A
(ja)
*
|
2020-08-13 |
2023-09-07 |
イェール ユニバーシティー |
所望の表現型を有するcar t細胞の操作および選択のための組成物および方法
|
CN111979273B
(zh)
*
|
2020-08-24 |
2022-05-27 |
苏州启辰生物科技有限公司 |
一种制备人源化ace2小鼠模型的方法
|
EP4204436A1
(en)
|
2020-08-28 |
2023-07-05 |
Pairwise Plants Services, Inc. |
Engineered crispr-cas proteins and methods of use thereof
|
AU2021338299A1
(en)
|
2020-09-01 |
2023-04-20 |
64-X, Inc. |
Mammalian cells and methods for engineering the same
|
US12012621B2
(en)
|
2020-09-02 |
2024-06-18 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for RNA-guided RNA-targeting CRISPR effectors
|
IL301139A
(en)
|
2020-09-11 |
2023-05-01 |
Lifeedit Therapeutics Inc |
Dna modifying enzymes and active fragments and variants thereof and methods of use
|
WO2022060749A1
(en)
|
2020-09-15 |
2022-03-24 |
Inscripta, Inc. |
Crispr editing to embed nucleic acid landing pads into genomes of live cells
|
JP2023543351A
(ja)
|
2020-09-18 |
2023-10-13 |
アーティザン ディヴェロップメント ラブス インコーポレイテッド |
効率的かつ特異的なゲノム編集のためのコンストラクト及びその使用
|
WO2022188039A1
(en)
|
2021-03-09 |
2022-09-15 |
Huigene Therapeutics Co., Ltd. |
Engineered crispr/cas13 system and uses thereof
|
WO2022068912A1
(en)
|
2020-09-30 |
2022-04-07 |
Huigene Therapeutics Co., Ltd. |
Engineered crispr/cas13 system and uses thereof
|
CA3195019A1
(en)
|
2020-10-06 |
2022-04-14 |
Maria Fardis |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
WO2022076606A1
(en)
|
2020-10-06 |
2022-04-14 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
US20230365995A1
(en)
|
2020-10-07 |
2023-11-16 |
Precision Biosciences, Inc. |
Lipid nanoparticle compositions
|
IL302220A
(en)
*
|
2020-10-19 |
2023-06-01 |
Caribou Biosciences Inc |
Dna-containing polynucleotides and guides for crispr type v systems, and methods of making and using the same
|
CR20230175A
(es)
|
2020-10-23 |
2023-07-26 |
Elo Life Systems Inc |
Métodos para producir plantas de vainilla con mejor sabor y producción agronómica
|
WO2022090224A1
(en)
|
2020-10-27 |
2022-05-05 |
KWS SAAT SE & Co. KGaA |
Use of enhanced pol theta activity for eukaryotic genome engineering
|
CN112300999A
(zh)
*
|
2020-11-02 |
2021-02-02 |
江苏集萃药康生物科技股份有限公司 |
一种balb/c小鼠模型及其用途
|
JPWO2022097663A1
(ru)
|
2020-11-06 |
2022-05-12 |
|
|
AU2021374974A1
(en)
|
2020-11-06 |
2023-05-25 |
Pairwise Plants Services, Inc. |
Compositions and methods for rna-encoded dna-replacement of alleles
|
US11512297B2
(en)
|
2020-11-09 |
2022-11-29 |
Inscripta, Inc. |
Affinity tag for recombination protein recruitment
|
EP4243608A1
(en)
|
2020-11-11 |
2023-09-20 |
Leibniz-Institut für Pflanzenbiochemie (IPB) |
Fusion protein for editing endogenous dna of a eukaryotic cell
|
CN112410355B
(zh)
*
|
2020-11-23 |
2022-03-25 |
昆明理工大学 |
一种酰基辅酶a氧化酶2基因rkacox2及其应用
|
CN112461807B
(zh)
*
|
2020-11-26 |
2021-11-19 |
山西大学 |
碳量子点在靶向细胞核仁免洗成像中的应用
|
WO2022120022A1
(en)
|
2020-12-02 |
2022-06-09 |
Regeneron Pharmaceuticals, Inc. |
Crispr sam biosensor cell lines and methods of use thereof
|
TW202237836A
(zh)
|
2020-12-03 |
2022-10-01 |
美商斯奎柏治療公司 |
工程化之第2類第v型crispr系統
|
CN113308451B
(zh)
*
|
2020-12-07 |
2023-07-25 |
中国科学院动物研究所 |
工程化的Cas效应蛋白及其使用方法
|
CN114634928B
(zh)
*
|
2020-12-15 |
2023-08-04 |
四川大学华西医院 |
一种降低stat3转录功能的核酸片段及其制药用途
|
US20220195405A1
(en)
*
|
2020-12-17 |
2022-06-23 |
Monsanto Technology Llc |
Engineered ssdnase-free crispr endonucleases
|
AU2021401302A1
(en)
|
2020-12-17 |
2023-07-06 |
Iovance Biotherapeutics, Inc. |
Treatment with tumor infiltrating lymphocyte therapies in combination with ctla-4 and pd-1 inhibitors
|
WO2022133149A1
(en)
|
2020-12-17 |
2022-06-23 |
Iovance Biotherapeutics, Inc. |
Treatment of cancers with tumor infiltrating lymphocytes
|
CA3206361A1
(en)
|
2020-12-23 |
2022-06-30 |
Flagship Pioneering Innovations V, Inc. |
In vitro assembly of anellovirus capsids enclosing rna
|
CN112553215A
(zh)
*
|
2020-12-24 |
2021-03-26 |
山东农业大学 |
一个玉米纹枯病抗病相关基因ZmFAH49及其应用
|
CN112662670B
(zh)
*
|
2020-12-25 |
2024-04-02 |
河南省农业科学院 |
花生脂酰-酰基载体蛋白硫酯酶AhFATB2基因启动子及其制备方法和应用
|
CN112640847B
(zh)
*
|
2020-12-30 |
2022-12-13 |
重庆医科大学附属第一医院 |
一种内源性癫痫发作动物模型及其构建方法
|
US11306298B1
(en)
|
2021-01-04 |
2022-04-19 |
Inscripta, Inc. |
Mad nucleases
|
EP4274890A4
(en)
|
2021-01-07 |
2024-11-27 |
Inscripta, Inc. |
MAD-NUCLEASES
|
JP2024502630A
(ja)
|
2021-01-12 |
2024-01-22 |
マーチ セラピューティクス, インコーポレイテッド |
コンテキスト依存性二本鎖dna特異的デアミナーゼ及びその使用
|
CN112680479A
(zh)
*
|
2021-01-13 |
2021-04-20 |
汪利平 |
Cyp1b1基因缺失斑马鱼的制备
|
CN114790456A
(zh)
*
|
2021-01-24 |
2022-07-26 |
东北林业大学 |
野菊u6基因及其应用
|
US20250127811A1
(en)
|
2021-01-28 |
2025-04-24 |
Precision Biosciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
US20240307437A1
(en)
|
2021-01-29 |
2024-09-19 |
Iovance Biotherapeutics, Inc. |
Cytokine associated tumor infiltrating lymphocytes compositions and methods
|
CN112877275B
(zh)
*
|
2021-02-04 |
2023-03-31 |
中国农业科学院兰州兽医研究所 |
Hdac2基因敲除的bhk-21细胞系及其构建方法和应用
|
CN112852745B
(zh)
*
|
2021-02-04 |
2023-05-23 |
中国农业科学院兰州兽医研究所 |
Hdac3基因敲除的bhk-21细胞系及其构建方法和应用
|
WO2022166895A1
(zh)
*
|
2021-02-05 |
2022-08-11 |
山东舜丰生物科技有限公司 |
Crispr酶和系统以及应用
|
CA3207601A1
(en)
|
2021-02-07 |
2022-08-11 |
Linyu SHI |
Rna adeno-associated virus (raav) vector and uses thereof
|
CA3210883A1
(en)
|
2021-02-09 |
2022-08-18 |
Sherlock Biosciences, Inc. |
Nucleic acid amplification using promoter primers
|
US20220259612A1
(en)
|
2021-02-11 |
2022-08-18 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying cytokinin oxidase levels in plants
|
US11884924B2
(en)
|
2021-02-16 |
2024-01-30 |
Inscripta, Inc. |
Dual strand nucleic acid-guided nickase editing
|
WO2022175878A1
(en)
*
|
2021-02-20 |
2022-08-25 |
Kcat Enzymatic Private Limited |
Insilico guided crispr-cas driven enzyme engineering framework
|
WO2022182801A1
(en)
|
2021-02-25 |
2022-09-01 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing, or modifying genes
|
CN117203227A
(zh)
|
2021-02-25 |
2023-12-08 |
成对植物服务股份有限公司 |
用于修饰植物中根结构的方法和组合物
|
IL305545A
(en)
|
2021-03-02 |
2023-10-01 |
BRAIN Biotech AG |
NOVEL CRISPR-Cas NUCLEASES FROM METAGENOMES
|
WO2022187406A1
(en)
|
2021-03-03 |
2022-09-09 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and a dgk inhibitor
|
CN115427561B
(zh)
|
2021-03-09 |
2024-06-04 |
辉大(上海)生物科技有限公司 |
工程化CRISPR/Cas13系统及其用途
|
TW202300507A
(zh)
*
|
2021-03-09 |
2023-01-01 |
美商阿伯生物技術公司 |
包含變異多肽之組合物及其用途
|
CN113005147A
(zh)
*
|
2021-03-11 |
2021-06-22 |
中山大学附属第一医院 |
一种usp8突变的小鼠动物模型的构建方法及其应用
|
US20240191191A1
(en)
|
2021-03-19 |
2024-06-13 |
Iovance Biotherapeutics, Inc. |
Methods for infiltrating lymphocyte (til) expansion related to cd39/cd69 selection and gene knockout in tils
|
JP2024511131A
(ja)
|
2021-03-22 |
2024-03-12 |
ライフエディット セラピューティクス,インコーポレイティド |
Dna改変酵素とその活性な断片およびバリアント、ならびに利用の方法
|
WO2022214522A2
(en)
|
2021-04-07 |
2022-10-13 |
Astrazeneca Ab |
Compositions and methods for site-specific modification
|
WO2022217086A1
(en)
|
2021-04-09 |
2022-10-13 |
Vor Biopharma Inc. |
Photocleavable guide rnas and methods of use thereof
|
EP4323501A1
(en)
|
2021-04-16 |
2024-02-21 |
Beam Therapeutics Inc. |
Genetic modification of hepatocytes
|
WO2022225981A2
(en)
|
2021-04-19 |
2022-10-27 |
Iovance Biotherapeutics, Inc. |
Chimeric costimulatory receptors, chemokine receptors, and the use of same in cellular immunotherapies
|
KR102428773B1
(ko)
*
|
2021-04-21 |
2022-08-05 |
(주)지플러스생명과학 |
분리형 crRNA 및 이를 이용한 CRISPR-Cas 시스템
|
WO2022226316A1
(en)
|
2021-04-22 |
2022-10-27 |
Precision Biosciences, Inc. |
Compositions and methods for generating male sterile plants
|
CA3218053A1
(en)
|
2021-05-06 |
2022-11-10 |
Artisan Development Labs, Inc. |
Modified nucleases
|
CA3219148A1
(en)
|
2021-05-17 |
2022-11-24 |
Frederick G. Vogt |
Pd-1 gene-edited tumor infiltrating lymphocytes and uses of same in immunotherapy
|
WO2022243437A1
(en)
|
2021-05-19 |
2022-11-24 |
KWS SAAT SE & Co. KGaA |
Sample preparation with oppositely oriented guide polynucleotides
|
CN113287569B
(zh)
*
|
2021-05-27 |
2023-04-07 |
四川康城生物科技有限公司 |
一种免疫低下动物模型的构建方法
|
US20220389418A1
(en)
|
2021-06-01 |
2022-12-08 |
Helmholtz-Institut Für Rna-Basierte Nfektionsforschung (Hzi) |
Rna-guided cas nucleases and uses thereof in diagnostics and therapy
|
WO2022256448A2
(en)
|
2021-06-01 |
2022-12-08 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing, or modifying genes
|
CA3222023A1
(en)
|
2021-06-01 |
2022-12-08 |
Arbor Biotechnologies, Inc. |
Gene editing systems comprising a crispr nuclease and uses thereof
|
CN113064220A
(zh)
*
|
2021-06-03 |
2021-07-02 |
四川九通智路科技有限公司 |
基于非线性自回归神经网络的能见度测量系统及测量方法
|
AU2022290278A1
(en)
|
2021-06-11 |
2024-01-04 |
LifeEDIT Therapeutics, Inc. |
Rna polymerase iii promoters and methods of use
|
WO2022265905A2
(en)
|
2021-06-14 |
2022-12-22 |
Pairwise Plants Services, Inc. |
Reporter constructs, compositions comprising the same, and methods of use thereof
|
US20240279719A1
(en)
*
|
2021-06-17 |
2024-08-22 |
The Board Of Trustees Of The University Of Illinois |
Crispr cascade
|
UY39822A
(es)
|
2021-06-17 |
2022-12-30 |
Pairwise Plants Services Inc |
Modificación de factores de transcripción de la familia de factores reguladores del crecimiento en s
|
EP4370676A2
(en)
|
2021-06-18 |
2024-05-22 |
Artisan Development Labs, Inc. |
Compositions and methods for targeting, editing or modifying human genes
|
UY39827A
(es)
|
2021-06-24 |
2023-01-31 |
Pairwise Plants Services Inc |
Modificación de genes de ubiquitina ligasa e3 hect para mejorar los rasgos de rendimiento
|
MX2023014883A
(es)
|
2021-07-01 |
2024-02-12 |
Pairwise Plants Services Inc |
Metodos y composiciones para mejorar el desarrollo del sistema radicular.
|
AU2022307018A1
(en)
*
|
2021-07-05 |
2024-02-15 |
Genkore Inc. |
Cleavage-inactive cas12f1, cleavage-inactive cas12f1-based fusion protein, crispr gene-editing system comprising same, and preparation method and use thereof
|
CN117987554A
(zh)
*
|
2021-07-06 |
2024-05-07 |
苏州淦江生物技术有限公司 |
一种基于Cas蛋白的检测方法
|
WO2023283585A2
(en)
|
2021-07-06 |
2023-01-12 |
Vor Biopharma Inc. |
Inhibitor oligonucleotides and methods of use thereof
|
EP4367242A2
(en)
|
2021-07-07 |
2024-05-15 |
Omega Therapeutics, Inc. |
Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expression
|
CN113383747B
(zh)
*
|
2021-07-09 |
2022-12-27 |
广西贺州农贝贝农牧科技有限公司 |
一种产蛋后期老龄鸡强制换羽的工艺方法
|
EP4367229A4
(en)
*
|
2021-07-09 |
2025-05-21 |
Acrigen Biosciences |
COMPOSITIONS AND METHODS FOR MAKING NUCLEIC ACID MODIFICATIONS
|
US20230052518A1
(en)
|
2021-07-12 |
2023-02-16 |
Labsimply, Inc. |
Nuclease cascade assay
|
US20240365776A1
(en)
|
2021-07-22 |
2024-11-07 |
Iovance Biotherapeutics, Inc |
Method for cryopreservation of solid tumor fragments
|
WO2023009716A1
(en)
|
2021-07-28 |
2023-02-02 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with kras inhibitors
|
CN118368974A
(zh)
|
2021-07-30 |
2024-07-19 |
科沃施种子欧洲股份两合公司 |
具有提高的消化率和标记单倍型的植物
|
WO2023015182A1
(en)
|
2021-08-02 |
2023-02-09 |
Vor Biopharma Inc. |
Compositions and methods for gene modification
|
US20230078990A1
(en)
|
2021-08-12 |
2023-03-16 |
Pairwise Plants Services, Inc. |
Modification of brassinosteroid receptor genes to improve yield traits
|
WO2023020938A1
(en)
|
2021-08-16 |
2023-02-23 |
Nunhems B.V. |
Lettuce plant having delayed bolting
|
WO2023023496A1
(en)
|
2021-08-17 |
2023-02-23 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying cytokinin receptor histidine kinase genes in plants
|
WO2023028444A1
(en)
*
|
2021-08-27 |
2023-03-02 |
Mammoth Biosciences, Inc. |
Effector proteins and methods of use
|
MX2024002276A
(es)
|
2021-08-30 |
2024-03-07 |
Pairwise Plants Services Inc |
Modificacion de genes de peptidasa de union a ubiquitinaen plantas para mejorar rasgos de rendimiento.
|
CN113584077B
(zh)
*
|
2021-08-31 |
2023-09-15 |
西南大学 |
沉默桑实杯盘菌关键致病基因CsGPA1的沉默载体及其应用和方法
|
AR126938A1
(es)
|
2021-09-02 |
2023-11-29 |
Pairwise Plants Services Inc |
Métodos y composiciones para mejorar la arquitectura de las plantas y los rasgos de rendimiento
|
CA3232804A1
(en)
|
2021-09-21 |
2023-03-30 |
Pairwise Plants Services, Inc. |
Methods and compositions for reducing pod shatter in canola
|
US20230266293A1
(en)
|
2021-09-21 |
2023-08-24 |
Pairwise Plants Services, Inc. |
Color-based and/or visual methods for identifying the presence of a transgene and compositions and constructs relating to the same
|
AR127144A1
(es)
|
2021-09-27 |
2023-12-20 |
Monsanto Technology Llc |
Composiciones y métodos para la transformación de explantes de embriones extirpados de semillas de monocotiledóneas
|
WO2023049926A2
(en)
|
2021-09-27 |
2023-03-30 |
Vor Biopharma Inc. |
Fusion polypeptides for genetic editing and methods of use thereof
|
WO2023052508A2
(en)
|
2021-09-30 |
2023-04-06 |
Astrazeneca Ab |
Use of inhibitors to increase efficiency of crispr/cas insertions
|
AR127236A1
(es)
|
2021-10-04 |
2024-01-03 |
Pairwise Plants Services Inc |
Métodos para mejorar la fertilidad de la flor y el rendimiento de semillas
|
KR102703683B1
(ko)
*
|
2021-10-06 |
2024-09-09 |
주식회사 진코어 |
유전자 편집을 위한 TaRGET 시스템 및 이의 용도
|
AR127300A1
(es)
|
2021-10-07 |
2024-01-10 |
Pairwise Plants Services Inc |
Métodos para mejorar la fertilidad de la flor y el rendimiento de semillas
|
WO2023064872A1
(en)
|
2021-10-14 |
2023-04-20 |
Precision Biosciences, Inc. |
Combinations of anti-bcma car t cells and gamma secretase inhibitors
|
EP4166670A1
(en)
|
2021-10-18 |
2023-04-19 |
KWS SAAT SE & Co. KGaA |
Plant-tag-based weeding control
|
MX2024004812A
(es)
|
2021-10-19 |
2024-07-15 |
Prec Biosciences Inc |
Métodos de edición génica para el tratamiento de la deficiencia de alfa-1 antitripsina (aat).
|
AR127482A1
(es)
|
2021-10-27 |
2024-01-31 |
Iovance Biotherapeutics Inc |
Sistemas y métodos para coordinar la fabricación de células para inmunoterapia específica de paciente
|
EP4423271A2
(en)
|
2021-10-28 |
2024-09-04 |
Regeneron Pharmaceuticals, Inc. |
Crispr/cas-related methods and compositions for knocking out c5
|
AU2022375820A1
(en)
|
2021-11-01 |
2024-06-13 |
Tome Biosciences, Inc. |
Single construct platform for simultaneous delivery of gene editing machinery and nucleic acid cargo
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
US20250032618A1
(en)
|
2021-11-10 |
2025-01-30 |
Iovance Biotherapeutics, Inc. |
Methods of expansion treatment utilizing cd8 tumor infiltrating lymphocytes
|
WO2023091910A1
(en)
|
2021-11-16 |
2023-05-25 |
Precision Biosciences, Inc. |
Methods for cancer immunotherapy
|
US20250025572A1
(en)
*
|
2021-11-29 |
2025-01-23 |
Editas Medicine, Inc. |
Engineered crispr/cas12a effector proteins, and uses thereof
|
CN114404429B
(zh)
*
|
2021-11-30 |
2023-06-30 |
重庆医科大学附属第二医院 |
一种纳米银修饰的单宁酸-铁网络的载药纳米复合物及其制备方法和逆转肿瘤耐药应用
|
CA3238939A1
(en)
|
2021-12-08 |
2023-06-15 |
Gaurang Patel |
Mutant myocilin disease model and uses thereof
|
AR127904A1
(es)
|
2021-12-09 |
2024-03-06 |
Pairwise Plants Services Inc |
Métodos para mejorar la fertilidad de floretes y el rendimiento de semillas
|
US20230295646A1
(en)
|
2021-12-13 |
2023-09-21 |
Pairwise Plants Services, Inc. |
Model editing systems and methods relating to the same
|
US11820983B2
(en)
|
2021-12-13 |
2023-11-21 |
Labsimply, Inc. |
Tuning cascade assay kinetics via molecular design
|
WO2023114090A2
(en)
*
|
2021-12-13 |
2023-06-22 |
Labsimply, Inc. |
Signal boost cascade assay
|
EP4453199A1
(en)
|
2021-12-21 |
2024-10-30 |
Benson Hill, Inc. |
Compositions and methods for modifying genomes
|
IL313765A
(en)
|
2021-12-22 |
2024-08-01 |
Tome Biosciences Inc |
Joint provision of a gene editor structure and a donor template
|
WO2023122800A1
(en)
|
2021-12-23 |
2023-06-29 |
University Of Massachusetts |
Therapeutic treatment for fragile x-associated disorder
|
GB2629276A
(en)
|
2022-01-06 |
2024-10-23 |
Pairwise Plants Services Inc |
Methods and compositions for trichome removal
|
WO2023135524A1
(en)
*
|
2022-01-12 |
2023-07-20 |
Genecker Co., Ltd. |
Cas9 proteins with enhanced specificity and uses thereof
|
IL314488A
(en)
|
2022-01-24 |
2024-09-01 |
Lifeedit Therapeutics Inc |
RNA-directed nucleases and active fragments and their variants and methods of use
|
JP2025504908A
(ja)
|
2022-01-28 |
2025-02-19 |
アイオバンス バイオセラピューティクス,インコーポレイテッド |
サイトカイン関連腫瘍浸潤リンパ球組成物及び方法
|
AR128372A1
(es)
|
2022-01-31 |
2024-04-24 |
Pairwise Plants Services Inc |
Supresión de la respuesta de evitación de la sombra en las plantas
|
US20230338477A1
(en)
|
2022-02-02 |
2023-10-26 |
Regeneron Pharmaceuticals, Inc. |
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease
|
CN118843637A
(zh)
|
2022-02-11 |
2024-10-25 |
东北农业大学 |
用于增加植物中蛋白质和/或油含量和改变油特性的方法和组合物
|
JP2025508723A
(ja)
*
|
2022-02-18 |
2025-04-10 |
プルモバイオティクス,エス.エル. |
細菌を操作するためのシステム、ツール、及び方法
|
US20230383271A1
(en)
|
2022-02-28 |
2023-11-30 |
Pairwise Plants Services, Inc. |
Engineered proteins and methods of use thereof
|
KR20240152394A
(ko)
|
2022-03-01 |
2024-10-21 |
에피크리스피알 바이오테크놀로지스, 인크. |
조작된 뉴클레아제, 그의 조성물 및 사용 방법
|
WO2023167882A1
(en)
|
2022-03-01 |
2023-09-07 |
Artisan Development Labs, Inc. |
Composition and methods for transgene insertion
|
WO2023168217A1
(en)
|
2022-03-02 |
2023-09-07 |
Pairwise Plants Services, Inc. |
Modification of brassinosteroid receptor genes to improve yield traits
|
CN114271237B
(zh)
*
|
2022-03-07 |
2022-05-27 |
南京农业大学 |
一种长短绒自别雌雄鸽的培育方法
|
WO2023169410A1
(zh)
|
2022-03-08 |
2023-09-14 |
中国科学院遗传与发育生物学研究所 |
胞嘧啶脱氨酶及其在碱基编辑中的用途
|
PE20250266A1
(es)
|
2022-03-31 |
2025-01-29 |
Pairwise Plants Services Inc |
Plantas rosaceae de floracion temprana con caracteristicas mejoradas
|
CN114592023B
(zh)
*
|
2022-03-31 |
2023-03-24 |
杭州优玛达生物科技有限公司 |
一种细胞裂解自组装多肽复合物、自组装方法、自组装多肽制剂及应用
|
WO2023196877A1
(en)
|
2022-04-06 |
2023-10-12 |
Iovance Biotherapeutics, Inc. |
Treatment of nsclc patients with tumor infiltrating lymphocyte therapies
|
AU2023251095A1
(en)
|
2022-04-07 |
2024-10-17 |
Monsanto Technology Llc |
Methods and compositions for improving resistance to fusarium head blight
|
WO2023201369A1
(en)
|
2022-04-15 |
2023-10-19 |
Iovance Biotherapeutics, Inc. |
Til expansion processes using specific cytokine combinations and/or akti treatment
|
WO2023205744A1
(en)
|
2022-04-20 |
2023-10-26 |
Tome Biosciences, Inc. |
Programmable gene insertion compositions
|
WO2023205714A1
(en)
|
2022-04-21 |
2023-10-26 |
Pairwise Plants Services, Inc. |
Methods and compositions for improving yield traits
|
JP2025514304A
(ja)
|
2022-04-29 |
2025-05-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
遺伝子治療法のための組織特異的遺伝子外セーフハーバーの同定
|
CN119452082A
(zh)
|
2022-05-02 |
2025-02-14 |
成对植物服务股份有限公司 |
用于提高产量和抗病性的方法和组合物
|
WO2023215831A1
(en)
|
2022-05-04 |
2023-11-09 |
Tome Biosciences, Inc. |
Guide rna compositions for programmable gene insertion
|
US20230416767A1
(en)
|
2022-05-05 |
2023-12-28 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying root architecture and/or improving plant yield traits
|
CN119604610A
(zh)
|
2022-05-09 |
2025-03-11 |
瑞泽恩制药公司 |
用于体内抗体产生的载体和方法
|
WO2023220608A1
(en)
|
2022-05-10 |
2023-11-16 |
Iovance Biotherapeutics, Inc. |
Treatment of cancer patients with tumor infiltrating lymphocyte therapies in combination with an il-15r agonist
|
WO2023225670A2
(en)
|
2022-05-20 |
2023-11-23 |
Tome Biosciences, Inc. |
Ex vivo programmable gene insertion
|
WO2023225410A2
(en)
|
2022-05-20 |
2023-11-23 |
Artisan Development Labs, Inc. |
Systems and methods for assessing risk of genome editing events
|
WO2023230578A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating circulating factors
|
AU2023276714A1
(en)
|
2022-05-25 |
2024-11-21 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulation of immune responses
|
WO2023230566A2
(en)
|
2022-05-25 |
2023-11-30 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating cytokines
|
EP4532771A2
(en)
|
2022-05-25 |
2025-04-09 |
Flagship Pioneering Innovations VII, LLC |
Compositions and methods for modulation of tumor suppressors and oncogenes
|
WO2023230498A1
(en)
|
2022-05-25 |
2023-11-30 |
Massachusetts Institute Of Technology |
Systems, methods, and compositions for rna-guided rna-targeting crispr effectors with cas7-11 variants
|
CN114934031B
(zh)
*
|
2022-05-25 |
2023-08-01 |
广州瑞风生物科技有限公司 |
新型Cas效应蛋白、基因编辑系统及用途
|
AU2023277636A1
(en)
|
2022-05-25 |
2024-11-21 |
Flagship Pioneering Innovations Vii, Llc |
Compositions and methods for modulating genetic drivers
|
CN119421951A
(zh)
|
2022-05-31 |
2025-02-11 |
瑞泽恩制药公司 |
用于c9orf72重复序列扩增疾病的crispr干扰疗法
|
WO2023235725A2
(en)
|
2022-05-31 |
2023-12-07 |
Regeneron Pharmaceuticals, Inc. |
Crispr-based therapeutics for c9orf72 repeat expansion disease
|
AR129505A1
(es)
|
2022-06-01 |
2024-09-04 |
Inst Genetics & Developmental Biology Cas |
Novedoso sistema de edición de genes crispr
|
AU2023289696A1
(en)
|
2022-06-24 |
2025-01-16 |
Tune Therapeutics, Inc. |
Compositions, systems, and methods for reducing low-density lipoprotein through targeted gene repression
|
AR129709A1
(es)
|
2022-06-27 |
2024-09-18 |
Pairwise Plants Services Inc |
Métodos y composiciones para modificar el escape a la sombra en plantas
|
WO2024006791A1
(en)
|
2022-06-29 |
2024-01-04 |
Pairwise Plants Services, Inc. |
Methods and compositions for controlling meristem size for crop improvement
|
AR129748A1
(es)
|
2022-06-29 |
2024-09-25 |
Pairwise Plants Services Inc |
Métodos y composiciones para controlar el tamaño del meristemo para el mejoramiento de cultivos
|
EP4299733A1
(en)
|
2022-06-30 |
2024-01-03 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
EP4299739A1
(en)
|
2022-06-30 |
2024-01-03 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024005863A1
(en)
|
2022-06-30 |
2024-01-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024005864A1
(en)
|
2022-06-30 |
2024-01-04 |
Inari Agriculture Technology, Inc. |
Compositions, systems, and methods for genome editing
|
WO2024020587A2
(en)
|
2022-07-22 |
2024-01-25 |
Tome Biosciences, Inc. |
Pleiopluripotent stem cell programmable gene insertion
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
CN119768514A
(zh)
|
2022-08-04 |
2025-04-04 |
成对植物服务股份有限公司 |
用于改善产量性状的方法和组合物
|
WO2024036240A1
(en)
|
2022-08-11 |
2024-02-15 |
Pairwise Plants Services, Inc. |
Methods and compositions for controlling meristem size for crop improvement
|
KR20250058785A
(ko)
|
2022-08-12 |
2025-04-30 |
라이프 에디트 테라퓨틱스, 인크. |
Rna-가이드된 뉴클레아제 및 그의 활성 단편 및 변이체 및 사용 방법
|
WO2024038168A1
(en)
|
2022-08-19 |
2024-02-22 |
UCB Biopharma SRL |
Novel rna-guided nucleases and nucleic acid targeting systems comprising such
|
AU2023329386A1
(en)
|
2022-08-25 |
2025-04-03 |
Massachusetts Institute Of Technology |
Programmable rna writing using crispr effectors and trans-splicing templates
|
AU2023331255A1
(en)
|
2022-08-25 |
2025-03-27 |
Life Edit Therapeutics, Inc. |
Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing
|
AU2023329149A1
(en)
|
2022-08-26 |
2025-02-20 |
KWS SAAT SE & Co. KGaA |
Use of paired genes in hybrid breeding
|
WO2024042168A1
(en)
|
2022-08-26 |
2024-02-29 |
UCB Biopharma SRL |
Novel rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases
|
WO2024042165A2
(en)
|
2022-08-26 |
2024-02-29 |
UCB Biopharma SRL |
Novel rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases
|
WO2024050548A2
(en)
*
|
2022-09-02 |
2024-03-07 |
Hunterian Medicine Llc |
Compact promoters for targeting hypoxia induced genes
|
WO2024047561A1
(en)
|
2022-09-02 |
2024-03-07 |
Janssen Biotech, Inc. |
Biomaterials and processes for immune synapse modulation of hypoimmunogenicity
|
WO2024054880A1
(en)
|
2022-09-08 |
2024-03-14 |
Pairwise Plants Services, Inc. |
Methods and compositions for improving yield characteristics in plants
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|
WO2024062138A1
(en)
|
2022-09-23 |
2024-03-28 |
Mnemo Therapeutics |
Immune cells comprising a modified suv39h1 gene
|
IL319122A
(en)
|
2022-09-28 |
2025-04-01 |
Regeneron Pharma |
Different antibody-resistant receptors improve cell-based therapies
|
WO2024073751A1
(en)
|
2022-09-29 |
2024-04-04 |
Vor Biopharma Inc. |
Methods and compositions for gene modification and enrichment
|
WO2024073114A1
(en)
|
2022-09-30 |
2024-04-04 |
Vedabio, Inc. |
Delivery of therapeutics in vivo via a crispr-based cascade system
|
WO2024076473A1
(en)
*
|
2022-10-02 |
2024-04-11 |
Vedabio, Inc. |
Dimerization screening assays
|
US11965205B1
(en)
|
2022-10-14 |
2024-04-23 |
Vedabio, Inc. |
Detection of nucleic acid and non-nucleic acid target molecules
|
WO2024083579A1
(en)
|
2022-10-20 |
2024-04-25 |
Basf Se |
Regulatory nucleic acid molecules for enhancing gene expression in plants
|
TW202434726A
(zh)
|
2022-11-04 |
2024-09-01 |
美商生命編輯治療學公司 |
具內部插入位進化腺嘌呤去胺及rna引導之核酸酶融合蛋白及其使用方法
|
US20240182561A1
(en)
|
2022-11-04 |
2024-06-06 |
Regeneron Pharmaceuticals, Inc. |
Calcium voltage-gated channel auxiliary subunit gamma 1 (cacng1) binding proteins and cacng1-mediated delivery to skeletal muscle
|
WO2024098024A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Expansion of tumor infiltrating lymphocytes from liquid tumors and therapeutic uses thereof
|
WO2024098027A1
(en)
|
2022-11-04 |
2024-05-10 |
Iovance Biotherapeutics, Inc. |
Methods for tumor infiltrating lymphocyte (til) expansion related to cd39/cd103 selection
|
WO2024102277A2
(en)
|
2022-11-07 |
2024-05-16 |
Syngenta Crop Protection Ag |
Genes altering soy plant flowering time and/or maturation and uses thereof
|
WO2024100604A1
(en)
|
2022-11-09 |
2024-05-16 |
Juno Therapeutics Gmbh |
Methods for manufacturing engineered immune cells
|
WO2024102434A1
(en)
|
2022-11-10 |
2024-05-16 |
Senda Biosciences, Inc. |
Rna compositions comprising lipid nanoparticles or lipid reconstructed natural messenger packs
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
AU2023385185A1
(en)
|
2022-11-21 |
2025-05-08 |
Iovance Biotherapeutics, Inc. |
Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom
|
WO2024118836A1
(en)
|
2022-11-30 |
2024-06-06 |
Iovance Biotherapeutics, Inc. |
Processes for production of tumor infiltrating lymphocytes with shortened rep step
|
WO2024130102A2
(en)
|
2022-12-16 |
2024-06-20 |
Pairwise Plants Services, Inc. |
Fusion proteins comprising an intein polypeptide and methods of use thereof
|
WO2024127370A1
(en)
|
2022-12-16 |
2024-06-20 |
LifeEDIT Therapeutics, Inc. |
Guide rnas that target trac gene and methods of use
|
WO2024127369A1
(en)
|
2022-12-16 |
2024-06-20 |
LifeEDIT Therapeutics, Inc. |
Guide rnas that target foxp3 gene and methods of use
|
WO2024137911A1
(en)
|
2022-12-21 |
2024-06-27 |
Pairwise Plants Services, Inc. |
Engineered proteins and methods of use thereof
|
WO2024138194A1
(en)
|
2022-12-22 |
2024-06-27 |
Tome Biosciences, Inc. |
Platforms, compositions, and methods for in vivo programmable gene insertion
|
CN118275664A
(zh)
*
|
2022-12-30 |
2024-07-02 |
上海吐露港生物科技有限公司 |
基于拆分Cas蛋白的非核酸靶标检测方法及应用
|
WO2024253707A2
(en)
|
2023-01-07 |
2024-12-12 |
Vedabio, Inc. |
Engineered nucleic acid-guided nucleases
|
WO2024151493A1
(en)
|
2023-01-10 |
2024-07-18 |
Vedabio, Inc. |
Sample splitting for multiplexed detection of nucleic acids without amplification
|
WO2024161021A1
(en)
|
2023-02-03 |
2024-08-08 |
Juno Therapeutics Gmbh |
Methods for non-viral manufacturing of engineered immune cells
|
KR20250054815A
(ko)
*
|
2023-02-10 |
2025-04-23 |
주식회사 엔세이지 |
신규 CRISPR/Cas12a 조성물 및 이의 표적 핵산 검출 용도
|
US20240301447A1
(en)
|
2023-02-15 |
2024-09-12 |
Arbor Biotechnologies, Inc. |
Gene editing method for inhibiting aberrant splicing in stathmin 2 (stmn2) transcript
|
WO2024173622A1
(en)
|
2023-02-16 |
2024-08-22 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying shade avoidance in plants
|
WO2024175308A1
(en)
|
2023-02-22 |
2024-08-29 |
KWS SAAT SE & Co. KGaA |
Plants with improved performance
|
CN116355878B
(zh)
*
|
2023-02-28 |
2024-04-26 |
华中农业大学 |
新型TnpB编程性核酸酶及其应用
|
US20240327811A1
(en)
|
2023-03-01 |
2024-10-03 |
Pairwise Plants Services, Inc. |
Engineered proteins and methods of use thereof
|
WO2024182658A1
(en)
|
2023-03-02 |
2024-09-06 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying shade avoidance in plants
|
WO2024186950A1
(en)
|
2023-03-09 |
2024-09-12 |
Pairwise Plants Services, Inc. |
Modification of brassinosteroid signaling pathway genes for improving yield traits in plants
|
WO2024192291A1
(en)
|
2023-03-15 |
2024-09-19 |
Renagade Therapeutics Management Inc. |
Delivery of gene editing systems and methods of use thereof
|
WO2024201368A1
(en)
|
2023-03-29 |
2024-10-03 |
Astrazeneca Ab |
Use of inhibitors to increase efficiency of crispr/cas insertions
|
WO2024206375A1
(en)
|
2023-03-30 |
2024-10-03 |
Pairwise Plants Services, Inc. |
Methods and compositions for reducing thorns or prickles in plants
|
WO2024211306A1
(en)
|
2023-04-03 |
2024-10-10 |
Sutro Biopharma, Inc. |
Rf1 ko e. coli strains
|
WO2024211287A1
(en)
|
2023-04-03 |
2024-10-10 |
Seagen Inc. |
Production cell lines with targeted integration sites
|
WO2024216118A1
(en)
|
2023-04-14 |
2024-10-17 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
WO2024216116A1
(en)
|
2023-04-14 |
2024-10-17 |
Precision Biosciences, Inc. |
Muscle-specific expression cassettes
|
WO2024218295A1
(en)
|
2023-04-21 |
2024-10-24 |
Vib Vzw |
Allelic combinations in crops for yield increase
|
CN116751763B
(zh)
*
|
2023-05-08 |
2024-02-13 |
珠海舒桐医疗科技有限公司 |
一种Cpf1蛋白、V型基因编辑系统及应用
|
WO2024234006A1
(en)
|
2023-05-11 |
2024-11-14 |
Tome Biosciences, Inc. |
Systems, compositions, and methods for targeting liver sinusodial endothelial cells (lsecs)
|
WO2024235991A1
(en)
|
2023-05-15 |
2024-11-21 |
UCB Biopharma SRL |
Rna-guided nucleases and nucleic acid targeting systems comprising such rna-guided nucleases
|
WO2024236547A1
(en)
|
2023-05-18 |
2024-11-21 |
Inceptor Bio, Llc |
Modified phagocytic cells expressing chimeric antigen receptors comprising a herpes virus entry mediator (hvem) co-stimulatory domain and uses thereof
|
WO2024238902A1
(en)
|
2023-05-18 |
2024-11-21 |
Pairwise Plants Services, Inc. |
Methods and compositions for improving yield characteristics in plants
|
WO2024243438A2
(en)
|
2023-05-23 |
2024-11-28 |
Omega Therapeutics, Inc. |
Compositions and methods for reducing cxcl9, cxcl10, and cxcl11 gene expression
|
WO2025003358A2
(en)
|
2023-06-29 |
2025-01-02 |
UCB Biopharma SRL |
Novel nucleic acid targeting systems comprising rna-guided nucleases
|
WO2025006963A1
(en)
|
2023-06-30 |
2025-01-02 |
Regeneron Pharmaceuticals, Inc. |
Methods and compositions for increasing homology-directed repair
|
CN116671491B
(zh)
*
|
2023-07-04 |
2024-01-23 |
四川省畜牧科学研究院 |
一种南江黄羊的种羊选育方法
|
CN116790559B
(zh)
*
|
2023-07-07 |
2023-11-28 |
山东舜丰生物科技有限公司 |
一种融合HNH结构域的V型Cas酶及其应用
|
US12291729B2
(en)
|
2023-07-07 |
2025-05-06 |
Shandong Shunfeng Biotechnology Co.Ltd. |
Engineered Cas protein and use thereof
|
US20250027101A1
(en)
|
2023-07-18 |
2025-01-23 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying root architecture in plants
|
WO2025022367A2
(en)
|
2023-07-27 |
2025-01-30 |
Life Edit Therapeutics, Inc. |
Rna-guided nucleases and active fragments and variants thereof and methods of use
|
WO2025024617A1
(en)
|
2023-07-27 |
2025-01-30 |
Pairwise Plants Services, Inc. |
Methods and compositions for modifying plant yield traits
|
US20250049896A1
(en)
|
2023-07-28 |
2025-02-13 |
Regeneron Pharmaceuticals, Inc. |
Anti-tfr:acid sphingomyelinase for treatment of acid sphingomyelinase deficiency
|
US20250041455A1
(en)
|
2023-07-28 |
2025-02-06 |
Regeneron Pharmaceuticals, Inc. |
Anti-tfr:gaa and anti-cd63:gaa insertion for treatment of pompe disease
|
WO2025029654A2
(en)
|
2023-07-28 |
2025-02-06 |
Regeneron Pharmaceuticals, Inc. |
Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertion
|
WO2025027166A1
(en)
|
2023-08-01 |
2025-02-06 |
Basf Plant Science Company Gmbh |
Increased resistance by expression of msbp1 protein
|
WO2025027133A1
(en)
|
2023-08-01 |
2025-02-06 |
KWS SAAT SE & Co. KGaA |
Method of improving gelation properties of alternative proteins
|
WO2025027134A1
(en)
|
2023-08-01 |
2025-02-06 |
KWS SAAT SE & Co. KGaA |
Method of reducing off-flavours in alternative proteins
|
WO2025027165A1
(en)
|
2023-08-01 |
2025-02-06 |
Basf Plant Science Company Gmbh |
Increased resistance by expression of an ics protein
|
WO2025049524A1
(en)
|
2023-08-28 |
2025-03-06 |
Regeneron Pharmaceuticals, Inc. |
Cxcr4 antibody-resistant modified receptors
|
WO2025046513A1
(en)
|
2023-08-29 |
2025-03-06 |
Inceptor Bio, Llc |
Methods of manufacturing myeloid-derived cells from hematopoietic stem cells and compositions and uses thereof
|
WO2025049959A2
(en)
|
2023-09-01 |
2025-03-06 |
Renagade Therapeutics Management Inc. |
Gene editing systems, compositions, and methods for treatment of vexas syndrome
|
WO2025050069A1
(en)
|
2023-09-01 |
2025-03-06 |
Tome Biosciences, Inc. |
Programmable gene insertion using engineered integration enzymes
|
WO2025054540A1
(en)
|
2023-09-08 |
2025-03-13 |
Iovance Biotherapeutics, Inc. |
Methods of gene-editing using programmable nucleases
|
KR102789465B1
(ko)
*
|
2023-09-20 |
2025-04-04 |
주식회사 엔세이지 |
신규 CRISPR/Cas12a 시스템 및 그 유전자 편집 용도
|
WO2025072453A1
(en)
|
2023-09-26 |
2025-04-03 |
Pairwise Plants Services, Inc. |
Engineered deaminases, compositions comprising the same, and methods of use thereof
|
WO2025076141A1
(en)
|
2023-10-03 |
2025-04-10 |
Inari Agriculture Technology, Inc. |
Viral delivery of grna to the scion
|
WO2025080537A1
(en)
|
2023-10-09 |
2025-04-17 |
Pairwise Plants Services, Inc. |
Circular permutants of cas12a
|
US20250122522A1
(en)
|
2023-10-11 |
2025-04-17 |
Pairwise Plants Services, Inc. |
Methods and compositions for improving crop yield traits
|
CN117286039B
(zh)
*
|
2023-11-27 |
2024-03-12 |
中国科学院天津工业生物技术研究所 |
一种菌丝形态优化的里氏木霉菌株及其应用
|